{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T02:30:33Z","timestamp":1793154633181,"version":"4.5.0"},"reference-count":781,"publisher":"The Endocrine Society","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Cushing's disease (CD), or pituitary-dependent Cushing's syndrome, is a severe endocrine disease caused by a corticotroph pituitary tumor and associated with increased morbidity and mortality. The first-line treatment for CD is pituitary surgery, which is followed by disease remission in around 78% and relapse in around 13% of patients during the 10-year period after surgery, so that nearly one third of patients experience in the long-term a failure of surgery and require an additional second-line treatment. Patients with persistent or recurrent CD require additional treatments, including pituitary radiotherapy, adrenal surgery, and\/or medical therapy. Pituitary radiotherapy is effective in controlling cortisol excess in a large percentage of patients, but it is associated with a considerable risk of hypopituitarism. Adrenal surgery is followed by a rapid and definitive control of cortisol excess in nearly all patients, but it induces adrenal insufficiency. Medical therapy has recently acquired a more important role compared to the past, due to the recent employment of novel compounds able to control cortisol secretion or action. Currently, medical therapy is used as a presurgical treatment, particularly for severe disease; or as postsurgical treatment, in cases of failure or incomplete surgical tumor resection; or as bridging therapy before, during, and after radiotherapy while waiting for disease control; or, in selected cases, as primary therapy, mainly when surgery is not an option. The adrenal-directed drug ketoconazole is the most commonly used drug, mainly because of its rapid action, whereas the glucocorticoid receptor antagonist, mifepristone, is highly effective in controlling clinical comorbidities, mainly glucose intolerance, thus being a useful treatment for CD when it is associated with diabetes mellitus. Pituitary-directed drugs have the advantage of acting at the site responsible for CD, the pituitary tumor. Among this group of drugs, the dopamine agonist cabergoline and the somatostatin analog pasireotide result in disease remission in a consistent subgroup of patients with CD. Recently, pasireotide has been approved for the treatment of CD when surgery has failed or when surgery is not an option, and mifepristone has been approved for the treatment of Cushing's syndrome when associated with impairment of glucose metabolism in case of the lack of a surgical indication. Recent experience suggests that the combination of different drugs may be able to control cortisol excess in a great majority of patients with CD.<\/jats:p>","DOI":"10.1210\/er.2013-1048","type":"journal-article","created":{"date-parts":[[2015,6,11]],"date-time":"2015-06-11T13:07:32Z","timestamp":1434028052000},"page":"385-486","source":"Crossref","is-referenced-by-count":420,"title":["The Treatment of Cushing's Disease"],"prefix":"10.1210","volume":"36","author":[{"given":"Rosario","family":"Pivonello","sequence":"first","affiliation":[{"name":"Dipartimento Di Medicina Clinica E Chirurgia, Sezione Di Endocrinologia, Universita' Federico II di Napoli, 80131 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"De Leo","sequence":"first","affiliation":[{"name":"Dipartimento Di Medicina Clinica E Chirurgia, Sezione Di Endocrinologia, Universita' Federico II di Napoli, 80131 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Cozzolino","sequence":"first","affiliation":[{"name":"Dipartimento Di Medicina Clinica E Chirurgia, Sezione Di Endocrinologia, Universita' Federico II di Napoli, 80131 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annamaria","family":"Colao","sequence":"first","affiliation":[{"name":"Dipartimento Di Medicina Clinica E Chirurgia, Sezione Di Endocrinologia, Universita' Federico II di Napoli, 80131 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"issue":"1","key":"2020071612075356500_B1","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ecl.2007.10.010","article-title":"Cushing's syndrome","volume":"37","author":"Pivonello","year":"2008","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"9522","key":"2020071612075356500_B2","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1016\/S0140-6736(06)68699-6","article-title":"Cushing's syndrome","volume":"367","author":"Newell-Price","year":"2006","journal-title":"Lancet"},{"key":"2020071612075356500_B3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000314297","article-title":"Epidemiology of Cushing's syndrome","volume":"92","author":"Steffensen","year":"2010","journal-title":"Neuroendocrinology"},{"issue":"12","key":"2020071612075356500_B4","doi-asserted-by":"crossref","first-page":"5593","DOI":"10.1210\/jc.2003-030871","article-title":"Diagnosis and complications of Cushing's syndrome: a consensus statement","volume":"88","author":"Arnaldi","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2020071612075356500_B5","first-page":"647","article-title":"The diagnosis and differential diagnosis of Cushing's syndrome and pseudo-Cushing's states","volume":"19","author":"Newell-Price","year":"1998","journal-title":"Endocr Rev"},{"issue":"5","key":"2020071612075356500_B6","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1210\/jc.2008-0125","article-title":"The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline","volume":"93","author":"Nieman","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2020071612075356500_B7","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1210\/jc.2007-2734","article-title":"Treatment of adrenocorticotropin-dependent Cushing's syndrome: a consensus statement","volume":"93","author":"Biller","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2020071612075356500_B8","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1530\/EJE-11-1095","article-title":"The burden of Cushing's disease: clinical and health-related quality of life aspects","volume":"167","author":"Feelders","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"2020071612075356500_B9","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1159\/000315813","article-title":"Mortality in Cushing's disease","volume":"92","author":"Clayton","year":"2010","journal-title":"Neuroendocrinology"},{"issue":"4","key":"2020071612075356500_B10","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1365-2265.1994.tb02486.x","article-title":"Morbidity and mortality in Cushing's disease: an epidemiological approach","volume":"40","author":"Etxabe","year":"1994","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"10","key":"2020071612075356500_B11","doi-asserted-by":"crossref","first-page":"821","DOI":"10.7326\/0003-4819-130-10-199905180-00015","article-title":"Long-term mortality after transsphenoidal surgery for Cushing disease","volume":"130","author":"Swearingen","year":"1999","journal-title":"Ann Intern Med"},{"issue":"5","key":"2020071612075356500_B12","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1046\/j.1365-2796.1999.00483.x","article-title":"The survival and well-being of patients treated for Cushing's syndrome","volume":"245","author":"Pikkarainen","year":"1999","journal-title":"J Intern Med"},{"issue":"1","key":"2020071612075356500_B13","first-page":"117","article-title":"Incidence and late prognosis of Cushing's syndrome: a population-based study","volume":"86","author":"Lindholm","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2020071612075356500_B14","doi-asserted-by":"crossref","first-page":"6348","DOI":"10.1210\/jc.2003-032180","article-title":"Transsphenoidal microsurgery for Cushing's disease: initial outcome and long-term results","volume":"89","author":"Hammer","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2020071612075356500_B15","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1210\/jc.2006-2112","article-title":"Mortality in patients treated for Cushing's disease is increased, compared with patients treated for nonfunctioning pituitary macroadenoma","volume":"92","author":"Dekkers","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2020071612075356500_B16","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1210\/jc.2010-1942","article-title":"Mortality and morbidity in Cushing's disease over 50 years in Stoke-on-Trent, UK: audit and meta-analysis of literature","volume":"96","author":"Clayton","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2020071612075356500_B17","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/j.1365-2265.2011.04124.x","article-title":"Mortality and morbidity in Cushing's syndrome in New Zealand","volume":"75","author":"Bolland","year":"2011","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"2020071612075356500_B18","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1210\/jc.2011-2957","article-title":"Outcome of Cushing's disease following transsphenoidal surgery in a single center over 20 years","volume":"97","author":"Hassan-Smith","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2020071612075356500_B19","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1530\/EJE-13-0320","article-title":"Mortality in Cushing's syndrome: data from 386 patients from a single tertiary referral center","volume":"169","author":"Yaneva","year":"2013","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"2020071612075356500_B20","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1530\/EJE-13-0569","article-title":"Mortality in Cushing's syndrome: systematic analysis of a large series with prolonged follow-up","volume":"169","author":"Ntali","year":"2013","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"2020071612075356500_B21","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1210\/jc.2012-2893","article-title":"Predictors of mortality and long-term outcomes in treated Cushing's disease: a study of 346 patients","volume":"98","author":"Lambert","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2020071612075356500_B22","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1210\/jc.2012-3582","article-title":"Multisystem morbidity and mortality in Cushing's syndrome: a cohort study","volume":"98","author":"Dekkers","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612075356500_B23","article-title":"Mission study: an international observational study on the mortality in Cushing's syndrome","author":"Pivonello"},{"issue":"3","key":"2020071612075356500_B24","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.ejim.2011.10.013","article-title":"Mortality in Cushing's syndrome: a systematic review and meta-analysis","volume":"23","author":"Graversen","year":"2012","journal-title":"Eur J Intern Med"},{"issue":"6","key":"2020071612075356500_B25","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1111\/j.1365-2265.2004.02168.x","article-title":"High cardiovascular risk in patients with Cushing's syndrome according to 1999 WHO\/ISH guidelines","volume":"61","author":"Mancini","year":"2004","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"2020071612075356500_B26","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.ecl.2005.01.010","article-title":"The metabolic syndrome and cardiovascular risk in Cushing's syndrome","volume":"34","author":"Pivonello","year":"2005","journal-title":"Endocrinol Metab Clin North Am"},{"key":"2020071612075356500_B27","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1159\/000318566","article-title":"Cardiovascular disease in Cushing's syndrome: heart versus vasculature","volume":"92","author":"De Leo","year":"2010","journal-title":"Neuroendocrinology"},{"issue":"6","key":"2020071612075356500_B28","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1210\/jc.2002-021558","article-title":"Cardiovascular risk factors and common carotid artery caliber and stiffness in patients with Cushing's disease during active disease and 1 year after disease remission","volume":"88","author":"Faggiano","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2020071612075356500_B29","first-page":"2664","article-title":"Persistence of increased cardiovascular risk in patients with Cushing's disease after five years of successful cure","volume":"84","author":"Colao","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612075356500_B30","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1055\/s-2006-944545","article-title":"Patients with Cushing's syndrome have increased intimal media thickness at different vascular levels: comparison with a population matched for similar cardiovascular risk factors","volume":"38","author":"Albiger","year":"2006","journal-title":"Horm Metab Res"},{"issue":"5","key":"2020071612075356500_B31","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1210\/jc.2012-3754","article-title":"Hypercortisolism is associated with increased coronary arterial atherosclerosis: analysis of noninvasive coronary angiography using multidetector computerized tomography","volume":"98","author":"Neary","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2020071612075356500_B32","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/s12020-007-0033-8","article-title":"Impairment of flow-mediated vasodilatation of brachial artery in patients with Cushing's syndrome","volume":"31","author":"Baykan","year":"2007","journal-title":"Endocrine"},{"issue":"3","key":"2020071612075356500_B33","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.beem.2006.07.006","article-title":"Hypertension in Cushing's syndrome","volume":"20","author":"Magiakou","year":"2006","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"2020071612075356500_B34","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1159\/000314315","article-title":"Hypertension in Cushing's syndrome: from pathogenesis to treatment","volume":"92","author":"Cicala","year":"2010","journal-title":"Neuroendocrinology"},{"issue":"2","key":"2020071612075356500_B35","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1530\/EJE-13-0477","article-title":"Cushing's disease and hypertension: in vivo and in vitro study of the role of the renin-angiotensin-aldosterone system and effects of medical therapy","volume":"170","author":"van der Pas","year":"2014","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2020071612075356500_B36","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/HJH.0000000000000415","article-title":"The hypertension of Cushing's syndrome: controversies in the pathophysiology and focus on cardiovascular complications","volume":"33","author":"Isidori","year":"2015","journal-title":"J Hypertens"},{"key":"2020071612075356500_B37","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1055\/s-2007-992813","article-title":"Circadian blood pressure profile in patients with active Cushing's disease and after long-term cure","volume":"39","author":"Pecori Giraldi","year":"2007","journal-title":"Horm Metab Res"},{"key":"2020071612075356500_B38","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000314349","article-title":"Coagulopathy in Cushing's syndrome","volume":"92","author":"Trementino","year":"2010","journal-title":"Neuroendocrinology"},{"issue":"4","key":"2020071612075356500_B39","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/cen.12094","article-title":"Hypercoagulability in Cushing's syndrome: prevalence, pathogenesis and treatment","volume":"78","author":"van der Pas","year":"2013","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"8","key":"2020071612075356500_B40","first-page":"3662","article-title":"Anticoagulant prophylaxis markedly reduces thromboembolic complications in Cushing's syndrome","volume":"87","author":"Boscaro","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2020071612075356500_B41","doi-asserted-by":"crossref","first-page":"3745","DOI":"10.1210\/jc.2004-0079","article-title":"Hyperhomocysteinemia in patients with Cushing's syndrome","volume":"89","author":"Terzolo","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2020071612075356500_B42","doi-asserted-by":"crossref","first-page":"6616","DOI":"10.1210\/jc.2005-0656","article-title":"Sulfur amino acids in Cushing's disease: insight in homocysteine and taurine levels in patients with active and cured disease","volume":"90","author":"Faggiano","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2020071612075356500_B43","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1016\/S0735-1097(03)00493-5","article-title":"Left ventricular structural and functional characteristics in Cushing's syndrome","volume":"41","author":"Muiesan","year":"2003","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"2020071612075356500_B44","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1530\/EJE-09-0621","article-title":"Cardiac dysfunction is reversed upon successful treatment of Cushing's syndrome","volume":"162","author":"Pereira","year":"2010","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"2020071612075356500_B45","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/j.1365-2265.2011.04206.x","article-title":"Clinical relevance of cardiac structure and function abnormalities in patients with Cushing's syndrome before and after cure","volume":"76","author":"Toja","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"2020071612075356500_B46","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/BF03345677","article-title":"Cardiovascular autonomic function in Cushing's syndrome","volume":"32","author":"Fallo","year":"2009","journal-title":"J Endocrinol Invest"},{"issue":"3","key":"2020071612075356500_B47","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1210\/jc.2012-3547","article-title":"Coronary artery disease detected by multislice computed tomography in patients after long-term cure of Cushing's syndrome","volume":"98","author":"Barahona","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612075356500_B48","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1741-7015-9-48","article-title":"Metabolic syndrome: definitions and controversies","volume":"9","author":"Kassi","year":"2011","journal-title":"BMC Med"},{"key":"2020071612075356500_B49","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1159\/000314272","article-title":"Metabolic syndrome in Cushing's syndrome","volume":"92","author":"Chanson","year":"2010","journal-title":"Neuroendocrinology"},{"key":"2020071612075356500_B50","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1159\/000314316","article-title":"Management of diabetes mellitus in Cushing's syndrome","volume":"92","author":"Munir","year":"2010","journal-title":"Neuroendocrinology"},{"key":"2020071612075356500_B51","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1159\/000314319","article-title":"Pathophysiology of diabetes mellitus in Cushing's syndrome","volume":"92","author":"Pivonello","year":"2010","journal-title":"Neuroendocrinology"},{"issue":"2","key":"2020071612075356500_B52","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1530\/EJE-13-0754","article-title":"Is diabetes in Cushing's syndrome only a consequence of hypercortisolism?","volume":"170","author":"Giordano","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"2020071612075356500_B53","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1159\/000314213","article-title":"Pathophysiology of dyslipidemia in Cushing's syndrome","volume":"92","author":"Arnaldi","year":"2010","journal-title":"Neuroendocrinology"},{"key":"2020071612075356500_B54","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1159\/000314294","article-title":"Management of dyslipidemia in Cushing's syndrome","volume":"92","author":"Greenman","year":"2010","journal-title":"Neuroendocrinology"},{"key":"2020071612075356500_B55","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1136\/pgmj.62.729.657","article-title":"Cushing's syndrome\u2013transitory immune deficiency state?","volume":"62","author":"W\u00fcrzburger","year":"1986","journal-title":"Postgrad Med J"},{"key":"2020071612075356500_B56","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1056\/NEJM199505183322008","article-title":"The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation","volume":"332","author":"Chrousos","year":"1995","journal-title":"N Engl J Med"},{"key":"2020071612075356500_B57","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1749-6632.2012.06633.x","article-title":"Glucocorticoid regulation of inflammation and its functional correlates: from HPA axis to glucocorticoid receptor dysfunction","volume":"1261","author":"Silverman","year":"2012","journal-title":"Ann NY Acad Sci"},{"issue":"3","key":"2020071612075356500_B58","doi-asserted-by":"crossref","first-page":"334","DOI":"10.7326\/0003-4819-101-3-334","article-title":"Opportunistic infections in endogenous Cushing's syndrome","volume":"101","author":"Graham","year":"1984","journal-title":"Ann Intern Med"},{"issue":"5","key":"2020071612075356500_B59","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/BF03350337","article-title":"Cushing's syndrome complicated by multiple opportunistic infections","volume":"21","author":"Bakker","year":"1998","journal-title":"J Endocrinol Invest"},{"issue":"9398","key":"2020071612075356500_B60","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1016\/S0140-6736(03)14904-5","article-title":"Glucocorticoids and invasive fungal infections","volume":"362","author":"Lionakis","year":"2003","journal-title":"Lancet"},{"key":"2020071612075356500_B61","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000314317","article-title":"Neuropsychiatric disorders in Cushing's syndrome","volume":"92","author":"Pereira","year":"2010","journal-title":"Neuroendocrinology"},{"issue":"5","key":"2020071612075356500_B62","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2165\/00023210-200115050-00003","article-title":"Psychiatric disorders associated with Cushing's syndrome. Epidemiology, pathophysiology and treatment","volume":"15","author":"Sonino","year":"2001","journal-title":"CNS Drugs"},{"issue":"2","key":"2020071612075356500_B63","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s11154-009-9123-7","article-title":"Psychosomatic aspects of Cushing's syndrome","volume":"11","author":"Sonino","year":"2010","journal-title":"Rev Endocr Metab Disord"},{"issue":"6","key":"2020071612075356500_B64","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1159\/000029054","article-title":"Clinical correlates of major depression in Cushing's disease","volume":"31","author":"Sonino","year":"1998","journal-title":"Psychopathology"},{"issue":"8","key":"2020071612075356500_B65","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1176\/ajp.142.8.911","article-title":"Diagnostic categorization of psychiatric disturbance in Cushing's syndrome","volume":"142","author":"Haskett","year":"1985","journal-title":"Am J Psychiatry"},{"issue":"1","key":"2020071612075356500_B66","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/00006842-198102000-00002","article-title":"Depressed mood and other psychiatric manifestations of Cushing's syndrome: relationship to hormone levels","volume":"43","author":"Starkman","year":"1981","journal-title":"Psychosom Med"},{"issue":"3","key":"2020071612075356500_B67","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.ecl.2013.05.010","article-title":"Neuropsychiatric findings in Cushing syndrome and exogenous glucocorticoid administration","volume":"42","author":"Starkman","year":"2013","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"4","key":"2020071612075356500_B68","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1365-2265.1995.tb02614.x","article-title":"Psychopathology in patients with endogenous Cushing's syndrome: \u2018atypical\u2019 or melancholic features","volume":"43","author":"Dorn","year":"1995","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"7","key":"2020071612075356500_B69","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1176\/ajp.144.7.951","article-title":"Phenomenology and family history of affective disorder in Cushing's disease","volume":"144","author":"Hudson","year":"1987","journal-title":"Am J Psychiatry"},{"issue":"4","key":"2020071612075356500_B70","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1055\/s-2007-1014405","article-title":"Psychiatric phenomenology in Cushing's disease","volume":"25","author":"Loosen","year":"1992","journal-title":"Pharmacopsychiatry"},{"issue":"20","key":"2020071612075356500_B71","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.1001\/archinte.160.20.3045","article-title":"The diagnosis of Cushing's syndrome: atypical presentations and laboratory shortcomings","volume":"160","author":"Boscaro","year":"2000","journal-title":"Arch Intern Med"},{"issue":"3","key":"2020071612075356500_B72","first-page":"912","article-title":"The longitudinal course of psychopathology in Cushing's syndrome after correction of hypercortisolism","volume":"82","author":"Dorn","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2020071612075356500_B73","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S0090-3019(99)00197-4","article-title":"Cerebral atrophy in Cushing's disease","volume":"53","author":"Simmons","year":"2000","journal-title":"Surg Neurol"},{"issue":"5","key":"2020071612075356500_B74","first-page":"1949","article-title":"Loss of brain volume in endogenous Cushing's syndrome and its reversibility after correction of hypercortisolism","volume":"87","author":"Bourdeau","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2020071612075356500_B75","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1210\/jc.2009-2032","article-title":"Subtle cognitive impairments in patients with long-term cure of Cushing's disease","volume":"95","author":"Tiemensma","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"2020071612075356500_B76","doi-asserted-by":"crossref","first-page":"E1640","DOI":"10.1210\/jc.2012-1945","article-title":"Long-term cognitive impairments and attentional deficits in patients with Cushing's disease and cortisol-producing adrenal adenoma in remission","volume":"97","author":"Ragnarsson","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2020071612075356500_B77","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1530\/EJE-07-0762","article-title":"Evaluation of health-related quality of life in patients with Cushing's syndrome with a new questionnaire","volume":"158","author":"Webb","year":"2008","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"2020071612075356500_B78","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1210\/jc.2004-1375","article-title":"Quality of life in patients after long-term biochemical cure of Cushing's disease","volume":"90","author":"van Aken","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2020071612075356500_B79","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1530\/EJE-12-0308","article-title":"Impaired quality of life in patients in long-term remission of Cushing's syndrome of both adrenal and pituitary origin: a remaining effect of long-standing hypercortisolism?","volume":"167","author":"Wagenmakers","year":"2012","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"2020071612075356500_B80","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1111\/j.1365-2265.2012.04344.x","article-title":"Quality of life in patients with Cushing's disease: a modern approach","volume":"76","author":"Colao","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"2020071612075356500_B81","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1111\/j.1365-2265.2011.04191.x","article-title":"The development of the Tuebingen Cushing's disease quality of life inventory (Tuebingen CD-25). Part I: construction and psychometric properties","volume":"76","author":"Milian","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"2020071612075356500_B82","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1111\/j.1365-2265.2011.04280.x","article-title":"The development of the Tuebingen Cushing's disease quality of life inventory (Tuebingen CD-25). Part II: normative data from 1784 healthy people","volume":"76","author":"Milian","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"8","key":"2020071612075356500_B83","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1590\/S0004-27302007000800025","article-title":"Cushing's syndrome: aftermath of the cure","volume":"51","author":"Pivonello","year":"2007","journal-title":"Arq Bras Endocrinol Metabol"},{"issue":"4","key":"2020071612075356500_B84","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1210\/edrv-14-4-443","article-title":"The medical treatment of Cushing's syndrome","volume":"14","author":"Miller","year":"1993","journal-title":"Endocr Rev"},{"issue":"5","key":"2020071612075356500_B85","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/nrendo.2011.12","article-title":"Management of Cushing disease","volume":"7","author":"Tritos","year":"2011","journal-title":"Nat Rev Endocrinol"},{"issue":"2","key":"2020071612075356500_B86","first-page":"109","article-title":"The therapy of Cushing's disease in adults and children: an update","volume":"45","author":"Juszczak","year":"2013","journal-title":"Horm Metab Res"},{"issue":"5","key":"2020071612075356500_B87","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.beem.2009.06.001","article-title":"Cushing's disease","volume":"23","author":"Bertagna","year":"2009","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"2","key":"2020071612075356500_B88","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2165\/00024677-200201020-00002","article-title":"Classic and recent etiologies of Cushing's syndrome: diagnosis and therapy","volume":"1","author":"Beauregard","year":"2002","journal-title":"Treat Endocrinol"},{"issue":"8","key":"2020071612075356500_B89","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1590\/S0004-27302007000800023","article-title":"Criteria of cure and remission in Cushing's disease: an update","volume":"51","author":"Czepielewski","year":"2007","journal-title":"Arq Bras Endocrinol Metabol"},{"issue":"2","key":"2020071612075356500_B90","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s11060-014-1508-0","article-title":"Detection of recurrent Cushing's disease: proposal for standardized patient monitoring following transsphenoidal surgery","volume":"119","author":"Ayala","year":"2014","journal-title":"J Neurooncol"},{"key":"2020071612075356500_B91","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/BF01405930","article-title":"Selective removal of hypersecreting pituitary adenomas? An analysis of endocrine function, operative and microscopical findings in 101 cases","volume":"35","author":"L\u00fcdecke","year":"1976","journal-title":"Acta Neurochir (Wien)"},{"issue":"181","key":"2020071612075356500_B92","first-page":"119","article-title":"The treatment of Cushing's disease by trans-sphenoidal hypophysectomy","volume":"46","author":"Carmalt","year":"1977","journal-title":"Q J Med"},{"issue":"1","key":"2020071612075356500_B93","first-page":"24","article-title":"Transsphenoidal removal of pituitary microadenoma in Cushing's disease","volume":"53","author":"Salassa","year":"1978","journal-title":"Mayo Clin Proc"},{"issue":"14","key":"2020071612075356500_B94","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1056\/NEJM197804062981401","article-title":"Cushing's disease. Selective trans-sphenoidal resection of pituitary microadenomas","volume":"298","author":"Tyrrell","year":"1978","journal-title":"N Engl J Med"},{"issue":"3","key":"2020071612075356500_B95","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1365-2265.1979.tb03081.x","article-title":"Evaluation of resection of pituitary microadenoma for the treatment of Cushing's disease in patients with radiologically normal sella turcica","volume":"11","author":"Wajchenberg","year":"1979","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"2020071612075356500_B96","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/0090-3019(81)90262-7","article-title":"Pituitary Cushing's syndrome and Nelson's syndrome: diagnostic criteria, surgical therapy, and results","volume":"16","author":"Guthrie","year":"1981","journal-title":"Surg Neurol"},{"issue":"4","key":"2020071612075356500_B97","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1017\/S0317167100044279","article-title":"Presidential address: XVII Canadian Congress of Neurological Sciences. Cushing's disease: 50 years later","volume":"9","author":"Hardy","year":"1982","journal-title":"Can J Neurol Sci"},{"issue":"2","key":"2020071612075356500_B98","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3171\/jns.1983.59.2.0195","article-title":"Transsphenoidal microsurgical management of Cushing's disease. Report of 100 cases","volume":"59","author":"Boggan","year":"1983","journal-title":"J Neurosurg"},{"issue":"5","key":"2020071612075356500_B99","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/j.1365-2265.1983.tb00041.x","article-title":"Long term results of radical hypophysectomy for Cushing's disease","volume":"19","author":"Thomas","year":"1983","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"2020071612075356500_B100","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1001\/archinte.1985.00360060174027","article-title":"Cushing's disease. A review","volume":"145","author":"Burch","year":"1985","journal-title":"Arch Intern Med"},{"issue":"4","key":"2020071612075356500_B101","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1177\/014107688507800404","article-title":"Long-term follow up of trans-sphenoidal hypophysectomy for Cushing's disease","volume":"78","author":"Brand","year":"1985","journal-title":"J R Soc Med"},{"issue":"1","key":"2020071612075356500_B102","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1530\/acta.0.1130005","article-title":"Transsphenoidal microsurgery for Cushing's disease","volume":"113","author":"Tagliaferri","year":"1986","journal-title":"Acta Endocrinol (Copenh)"},{"issue":"5","key":"2020071612075356500_B103","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1177\/014107688607900504","article-title":"Transsphenoidal surgery for Cushing's disease","volume":"79","author":"Fahlbusch","year":"1986","journal-title":"J R Soc Med"},{"issue":"2","key":"2020071612075356500_B104","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1227\/00006123-198708000-00015","article-title":"Long term results of transsphenoidal adenomectomy in patients with Cushing's disease","volume":"21","author":"Nakane","year":"1987","journal-title":"Neurosurgery"},{"issue":"2","key":"2020071612075356500_B105","doi-asserted-by":"crossref","first-page":"204","DOI":"10.3171\/jns.1987.66.2.0204","article-title":"Surgical treatment of Cushing's disease","volume":"66","author":"Chandler","year":"1987","journal-title":"J Neurosurg"},{"issue":"6","key":"2020071612075356500_B106","doi-asserted-by":"crossref","first-page":"487","DOI":"10.7326\/0003-4819-109-6-487","article-title":"Transsphenoidal microsurgery for Cushing disease. A report of 216 cases","volume":"109","author":"Mampalam","year":"1988","journal-title":"Ann Intern Med"},{"issue":"6","key":"2020071612075356500_B107","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1210\/jcem-69-6-1122","article-title":"Predictive factors for initial cure and relapse rate after pituitary surgery for Cushing's disease","volume":"69","author":"Pieters","year":"1989","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2020071612075356500_B108","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3171\/jns.1990.72.3.0363","article-title":"Cushing's disease: results of transsphenoidal microsurgery with emphasis on surgical failures","volume":"72","author":"Tindall","year":"1990","journal-title":"J Neurosurg"},{"issue":"1","key":"2020071612075356500_B109","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1365-2265.1993.tb00976.x","article-title":"Assessment of endocrine function after transsphenoidal surgery for Cushing's disease","volume":"38","author":"McCance","year":"1993","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"2020071612075356500_B110","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1365-2265.1993.tb00975.x","article-title":"Transsphenoidal resection in Cushing's disease: undetectable serum cortisol as the definition of successful treatment","volume":"38","author":"Trainer","year":"1993","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"2020071612075356500_B111","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1046\/j.1365-2265.1997.2541051.x","article-title":"Postoperative metyrapone test in the early assessment of outcome of pituitary surgery for Cushing's disease","volume":"47","author":"van Aken","year":"1997","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"2020071612075356500_B112","first-page":"63","article-title":"Outcomes of therapy for Cushing's disease due to adrenocorticotropin-secreting pituitary macroadenomas","volume":"83","author":"Blevins","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2020071612075356500_B113","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3171\/jns.1999.91.2.0175","article-title":"Complications in a contemporary series of patients who underwent transsphenoidal surgery for Cushing's disease","volume":"91","author":"Semple","year":"1999","journal-title":"J Neurosurg"},{"issue":"2","key":"2020071612075356500_B114","first-page":"440","article-title":"Diagnosis and management of Cushing's syndrome: results of an Italian multicentre study. Study Group of the Italian Society of Endocrinology on the Pathophysiology of the Hypothalamic-Pituitary-Adrenal Axis","volume":"84","author":"Invitti","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2020071612075356500_B115","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s007010170077","article-title":"Assessment of cure and recurrence after pituitary surgery for Cushing's disease","volume":"143","author":"Barbetta","year":"2001","journal-title":"Acta Neurochir (Wien)"},{"issue":"1","key":"2020071612075356500_B116","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3171\/jns.2001.95.1.0001","article-title":"Serum cortisol response to transsphenoidal surgery for Cushing disease","volume":"95","author":"Simmons","year":"2001","journal-title":"J Neurosurg"},{"issue":"4","key":"2020071612075356500_B117","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1046\/j.1365-2265.2002.01511.x","article-title":"Long-term follow-up results of transsphenoidal surgery for Cushing's disease in a single centre using strict criteria for remission","volume":"56","author":"Rees","year":"2002","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"2020071612075356500_B118","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1046\/j.0300-0664.2001.01444.x","article-title":"Undetectable postoperative cortisol does not always predict long-term remission in Cushing's disease: a single centre audit","volume":"56","author":"Yap","year":"2002","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"2020071612075356500_B119","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1530\/eje.0.1490195","article-title":"Long-term results of treatment in patients with ACTH-secreting pituitary macroadenomas","volume":"149","author":"Cannav\u00f2","year":"2003","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"2020071612075356500_B120","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1210\/jc.2003-031170","article-title":"Dynamics of serum cortisol levels after transsphenoidal surgery in a cohort of patients with Cushing's disease","volume":"89","author":"Rollin","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2020071612075356500_B121","doi-asserted-by":"crossref","first-page":"3371","DOI":"10.1210\/jc.2003-031908","article-title":"Pituitary magnetic resonance imaging findings do not influence surgical outcome in adrenocorticotropin-secreting microadenomas","volume":"89","author":"Salenave","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2020071612075356500_B122","doi-asserted-by":"crossref","first-page":"825","DOI":"10.3171\/jns.2005.103.5.0825","article-title":"Surgical management of adrenocorticotropic hormone-secreting macroadenomas: outcome and challenges in patients with Cushing's disease or Nelson's syndrome","volume":"103","author":"De Tommasi","year":"2005","journal-title":"J Neurosurg"},{"issue":"1","key":"2020071612075356500_B123","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1210\/jc.2005-1204","article-title":"Clinical review: early morning cortisol levels as a predictor of remission after transsphenoidal surgery for Cushing's disease","volume":"91","author":"Esposito","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612075356500_B124","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s00701-007-1133-1","article-title":"Early post-operative ACTH and cortisol as predictors of remission in Cushing's disease","volume":"149","author":"Acebes","year":"2007","journal-title":"Acta Neurochir (Wien)"},{"issue":"3","key":"2020071612075356500_B125","doi-asserted-by":"crossref","first-page":"E6","DOI":"10.3171\/foc.2007.23.3.8","article-title":"Cushing disease: use of perioperative serum cortisol measurements in early determination of success following pituitary surgery","volume":"23","author":"Krikorian","year":"2007","journal-title":"Neurosurg Focus"},{"issue":"8","key":"2020071612075356500_B126","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1590\/S0004-27302007000800022","article-title":"Prospective evaluation of transsphenoidal pituitary surgery in 108 patients with Cushing's disease","volume":"51","author":"Rollin","year":"2007","journal-title":"Arq Bras Endocrinol Metabol"},{"issue":"3","key":"2020071612075356500_B127","doi-asserted-by":"crossref","first-page":"E9","DOI":"10.3171\/foc.2007.23.3.11","article-title":"Current state of the art in the diagnosis and surgical treatment of Cushing disease: early experience with a purely endoscopic endonasal technique","volume":"23","author":"Dehdashti","year":"2007","journal-title":"Neurosurg Focus"},{"issue":"4","key":"2020071612075356500_B128","doi-asserted-by":"crossref","first-page":"751","DOI":"10.3171\/JNS\/2008\/109\/10\/0751","article-title":"Management of Cushing's disease: outcome in patients with microadenoma detected on pituitary magnetic resonance imaging","volume":"109","author":"Prevedello","year":"2008","journal-title":"J Neurosurg"},{"issue":"5","key":"2020071612075356500_B129","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.clineuro.2008.12.011","article-title":"Outcome of transsphenoidal surgery for Cushing's disease: a high remission rate in ACTH-secreting macroadenomas","volume":"111","author":"Fomekong","year":"2009","journal-title":"Clin Neurol Neurosurg"},{"key":"2020071612075356500_B130","doi-asserted-by":"crossref","first-page":"531","DOI":"10.3171\/2008.8.JNS08339","article-title":"Outcome of using the histological pseudocapsule as a surgical capsule in Cushing disease","volume":"111","author":"Jagannathan","year":"2009","journal-title":"J Neurosurg"},{"issue":"3","key":"2020071612075356500_B131","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1227\/01.NEU.0000374722.50042.FF","article-title":"Utility of the immediate postoperative cortisol concentrations in patients with Cushing's disease","volume":"67","author":"Sughrue","year":"2010","journal-title":"Neurosurgery"},{"issue":"3","key":"2020071612075356500_B132","doi-asserted-by":"crossref","first-page":"222","DOI":"10.14310\/horm.2002.1312","article-title":"Cushing's disease: results of treatment and factors affecting outcome","volume":"10","author":"Ammini","year":"2011","journal-title":"Hormones (Athens)"},{"issue":"1","key":"2020071612075356500_B133","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1227\/NEU.0b013e31822dda2c","article-title":"Transsphenoidal surgery for Cushing disease: experience with 136 patients","volume":"70","author":"Ciric","year":"2012","journal-title":"Neurosurgery"},{"issue":"3","key":"2020071612075356500_B134","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1530\/EJE-13-0325","article-title":"Endoscopic transsphenoidal pituitary surgery: a good and safe primary treatment option for Cushing's disease, even in case of macroadenomas or invasive adenomas","volume":"169","author":"Wagenmakers","year":"2013","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"2020071612075356500_B135","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1530\/EJE-12-0921","article-title":"Long-term remission and recurrence rates in Cushing's disease: predictive factors in a single-centre study","volume":"168","author":"Alexandraki","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"2020071612075356500_B136","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s10143-013-0506-6","article-title":"Early promising results for the endoscopic surgical treatment of Cushing's disease","volume":"37","author":"Berker","year":"2014","journal-title":"Neurosurg Rev"},{"issue":"2","key":"2020071612075356500_B137","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1227\/NEU.0b013e31827b966a","article-title":"Endoscopic transsphenoidal surgery for Cushing disease: techniques, outcomes, and predictors of remission","volume":"72","author":"Starke","year":"2013","journal-title":"Neurosurgery"},{"issue":"2","key":"2020071612075356500_B138","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1007\/s11102-012-0390-z","article-title":"The trans-sphenoidal resection of pituitary adenomas in elderly patients and surgical risk","volume":"16","author":"Locatelli","year":"2013","journal-title":"Pituitary"},{"key":"2020071612075356500_B139","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/s11102-014-0567-8","article-title":"Long-term remission and recurrence rate in a cohort of Cushing's disease: the need for long-term follow-up","volume":"18","author":"Aranda","year":"2015","journal-title":"Pituitary"},{"issue":"12","key":"2020071612075356500_B140","doi-asserted-by":"crossref","first-page":"5858","DOI":"10.1210\/jc.2003-030751","article-title":"Long-term predictive value of postsurgical cortisol concentrations for cure and risk of recurrence in Cushing's disease","volume":"88","author":"Pereira","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2020071612075356500_B141","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1210\/jc.2009-1672","article-title":"Delayed remission after transsphenoidal surgery in patients with Cushing's disease","volume":"95","author":"Valassi","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2020071612075356500_B142","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1210\/jcem-54-2-413","article-title":"Cushing's disease: transient secondary adrenal insufficiency after selective removal of pituitary microadenomas; evidence for a pituitary origin","volume":"54","author":"Fitzgerald","year":"1982","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2020071612075356500_B143","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s11154-010-9140-6","article-title":"Peri-operative management of Cushing's disease","volume":"11","author":"AbdelMannan","year":"2010","journal-title":"Rev Endocr Metab Disord"},{"issue":"7","key":"2020071612075356500_B144","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1210\/jc.2011-0456","article-title":"The postoperative basal cortisol and CRH tests for prediction of long-term remission from Cushing's disease after transsphenoidal surgery","volume":"96","author":"Lindsay","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2020071612075356500_B145","first-page":"5695","article-title":"The complete normalization of the adrenocortical function as the criterion of cure after transsphenoidal surgery for Cushing's disease","volume":"86","author":"Estrada","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2020071612075356500_B146","first-page":"3114","article-title":"Factors influencing the immediate and late outcome of Cushing's disease treated by transsphenoidal surgery: a retrospective study by the European Cushing's Disease Survey Group","volume":"80","author":"Bochicchio","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2020071612075356500_B147","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3171\/jns.1994.80.1.0037","article-title":"Early repeat surgery for persistent Cushing's disease","volume":"80","author":"Ram","year":"1994","journal-title":"J Neurosurg"},{"issue":"9","key":"2020071612075356500_B148","doi-asserted-by":"crossref","first-page":"5478","DOI":"10.1210\/jc.2004-2436","article-title":"Clinical review: the strategy of immediate reoperation for transsphenoidal surgery for Cushing's disease","volume":"90","author":"Locatelli","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2020071612075356500_B149","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/s11102-012-0455-z","article-title":"Remission rate after transsphenoidal surgery in patients with pathologically confirmed Cushing's disease, the role of cortisol, ACTH assessment and immediate reoperation: a large single center experience","volume":"16","author":"Hameed","year":"2013","journal-title":"Pituitary"},{"issue":"3","key":"2020071612075356500_B150","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1007\/s11102-011-0368-2","article-title":"Complications of endoscopic surgery of the pituitary adenomas: analysis of 570 patients and review of the literature","volume":"15","author":"Berker","year":"2012","journal-title":"Pituitary"},{"issue":"6","key":"2020071612075356500_B151","first-page":"1776","article-title":"Intraoperative adrenocorticotropin levels during transsphenoidal surgery for Cushing's disease do not predict cure","volume":"82","author":"Graham","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2020071612075356500_B152","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/BF03343818","article-title":"Adrenocorticotropin levels do not change during early recovery of transsphenoidal surgery for ACTH-secreting pituitary tumors","volume":"24","author":"Pimentel-Filho","year":"2001","journal-title":"J Endocrinol Invest"},{"issue":"10","key":"2020071612075356500_B153","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1007\/s701-002-8284-y","article-title":"Intra- and postoperative plasma ACTH concentrations in patients with Cushing's disease cured by transsphenoidal pituitary surgery","volume":"144","author":"Czirj\u00e1k","year":"2002","journal-title":"Acta Neurochir (Wien)"},{"issue":"1","key":"2020071612075356500_B154","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1055\/s-2003-37145","article-title":"The use of postoperative ACTH levels as a marker for successful transsphenoidal microsurgery in Cushing's disease","volume":"64","author":"Flitsch","year":"2003","journal-title":"Zentralbl Neurochir"},{"issue":"4","key":"2020071612075356500_B155","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1007\/s11102-011-0295-2","article-title":"The dynamics of post-operative plasma ACTH values following transsphenoidal surgery for Cushing's disease","volume":"14","author":"Srinivasan","year":"2011","journal-title":"Pituitary"},{"issue":"5","key":"2020071612075356500_B156","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1210\/jcem-66-5-1056","article-title":"Transsphenoidal pituitary surgery for the treatment of Cushing's disease: results in 64 patients and long term follow-up studies","volume":"66","author":"Guilhaume","year":"1988","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2020071612075356500_B157","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1530\/acta.0.1230423","article-title":"A critical evaluation of transsphenoidal pituitary surgery in the treatment of Cushing's disease: prediction of outcome","volume":"123","author":"Arnott","year":"1990","journal-title":"Acta Endocrinol (Copenh)"},{"issue":"4","key":"2020071612075356500_B158","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/j.1365-2265.1990.tb03890.x","article-title":"Transsphenoidal surgery for Cushing's disease: does what is removed determine the endocrine outcome?","volume":"33","author":"Burke","year":"1990","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"7","key":"2020071612075356500_B159","first-page":"2647","article-title":"Risk factors and long-term outcome in pituitary-dependent Cushing's disease","volume":"81","author":"Sonino","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2020071612075356500_B160","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/00006123-200207000-00008","article-title":"Transsphenoidal surgery for Cushing's disease: endocrinological follow-up monitoring of 82 patients","volume":"51","author":"Shimon","year":"2002","journal-title":"Neurosurgery"},{"issue":"5","key":"2020071612075356500_B161","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1365-2265.2005.02380.x","article-title":"Long-term remission rates after pituitary surgery for Cushing's disease: the need for long-term surveillance","volume":"63","author":"Atkinson","year":"2005","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"2020071612075356500_B162","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1210\/jc.2007-2013","article-title":"Late recurrences of Cushing's disease after initial successful transsphenoidal surgery","volume":"93","author":"Patil","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2020071612075356500_B163","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1507\/endocrj.EJ12-0109","article-title":"Recurrence of Cushing's disease after primary transsphenoidal surgery in a university hospital in Korea","volume":"59","author":"Kim","year":"2012","journal-title":"Endocr J"},{"issue":"4","key":"2020071612075356500_B164","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/j.1365-2265.2011.04268.x","article-title":"Contemporary microsurgical concept for the treatment of Cushing's disease: endocrine outcome in 83 consecutive patients","volume":"76","author":"Honegger","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071612075356500_B165","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1017\/S031716710001427X","article-title":"Impact of technique on Cushing disease outcome using strict remission criteria","volume":"40","author":"Alahmadi","year":"2013","journal-title":"Can J Neurol Sci"},{"issue":"2","key":"2020071612075356500_B166","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1530\/EJE-13-0634","article-title":"Long-term remission and recurrence rates after first and second transsphenoidal surgery for Cushing's disease: care reality in the Munich Metropolitan Region","volume":"170","author":"Dimopoulou","year":"2014","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"2020071612075356500_B167","first-page":"291","article-title":"Predicting relapse after transsphenoidal surgery for Cushing's disease","volume":"76","author":"Toms","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"2020071612075356500_B168","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1007\/BF03349020","article-title":"Treatment of Cushing's disease by transsphenoidal, pituitary microsurgery: prognosis factors and long-term follow-up","volume":"19","author":"Bakiri","year":"1996","journal-title":"J Endocrinol Invest"},{"issue":"5","key":"2020071612075356500_B169","doi-asserted-by":"crossref","first-page":"967","DOI":"10.3171\/jns.2003.98.5.0967","article-title":"Transsphenoidal microsurgical treatment of Cushing disease: postoperative assessment of surgical efficacy by application of an overnight low-dose dexamethasone suppression test","volume":"98","author":"Chen","year":"2003","journal-title":"J Neurosurg"},{"issue":"5","key":"2020071612075356500_B170","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1046\/j.1365-2265.2001.01261.x","article-title":"Transsphenoidal pituitary surgery in Cushing's disease: can we predict outcome?","volume":"54","author":"Chee","year":"2001","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"2020071612075356500_B171","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3171\/JNS\/2008\/108\/01\/0009","article-title":"Long-term results after microsurgery for Cushing disease: experience with 426 primary operations over 35 years","volume":"108","author":"Hofmann","year":"2008","journal-title":"J Neurosurg"},{"issue":"10","key":"2020071612075356500_B172","doi-asserted-by":"crossref","first-page":"3746","DOI":"10.1210\/jc.2006-0997","article-title":"Cushing's syndrome: important issues in diagnosis and management","volume":"91","author":"Findling","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2020071612075356500_B173","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1210\/jc.2008-2234","article-title":"A combined dexamethasone desmopressin test as an early marker of postsurgical recurrence in Cushing's disease","volume":"94","author":"Castinetti","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2020071612075356500_B174","first-page":"1640","article-title":"Optimal response criteria for the human CRH test in the differential diagnosis of ACTH-dependent Cushing's syndrome","volume":"87","author":"Newell-Price","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2020071612075356500_B175","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1046\/j.1365-2265.2003.01776.x","article-title":"The corticotrophin-releasing hormone test is the most reliable noninvasive method to differentiate pituitary from ectopic ACTH secretion in Cushing's syndrome","volume":"58","author":"Reimondo","year":"2003","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"2020071612075356500_B176","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1530\/eje.0.1300235","article-title":"Early postoperative evaluation in patients with Cushing's disease: usefulness of ovine corticotropin-releasing hormone test in the prediction of recurrence of disease","volume":"130","author":"Vignati","year":"1994","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"2020071612075356500_B177","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1210\/jcem-65-5-906","article-title":"The corticotropin-releasing hormone test in the postoperative evaluation of patients with Cushing's syndrome","volume":"65","author":"Avgerinos","year":"1987","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2020071612075356500_B178","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/00006123-199908000-00007","article-title":"What can predict postoperative \u201cendocrinological cure\u201d in Cushing's disease?","volume":"45","author":"Nishizawa","year":"1999","journal-title":"Neurosurgery"},{"issue":"1","key":"2020071612075356500_B179","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1046\/j.1365-2265.2002.01369.x","article-title":"Transsphenoidal surgery for Cushing's disease: defining cure and following outcome","volume":"56","author":"Newell-Price","year":"2002","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"2020071612075356500_B180","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1210\/jcem-64-6-1150","article-title":"Corticotropin-releasing hormone stimulation test before and after transsphenoidal selective microadenomectomy in 30 patients with Cushing's disease","volume":"64","author":"Schrell","year":"1987","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612075356500_B181","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1159\/000258677","article-title":"Biochemical predictors of outcome of pituitary surgery for Cushing's disease","volume":"91","author":"Alwani","year":"2010","journal-title":"Neuroendocrinology"},{"issue":"5","key":"2020071612075356500_B182","first-page":"1768","article-title":"Vasopressin receptor expression and mutation analysis in corticotropin-secreting tumors","volume":"81","author":"Dahia","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2020071612075356500_B183","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1046\/j.1365-2265.1998.00560.x","article-title":"Overexpression of vasopressin (V3) and corticotrophin-releasing hormone receptor genes in corticotroph tumours","volume":"49","author":"de Keyzer","year":"1998","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"2020071612075356500_B184","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/j.1365-2265.1993.tb00341.x","article-title":"The desmopressin stimulation test in the differential diagnosis of Cushing's syndrome","volume":"38","author":"Malerbi","year":"1993","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"2020071612075356500_B185","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1046\/j.1365-2265.1997.1330954.x","article-title":"Effect of desmopressin on ACTH and cortisol secretion in states of ACTH excess","volume":"46","author":"Colombo","year":"1997","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"2020071612075356500_B186","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1046\/j.1365-2265.1999.00830.x","article-title":"Assessment of cortisol and ACTH responses to the desmopressin test in patients with Cushing's syndrome and simple obesity","volume":"51","author":"Tsagarakis","year":"1999","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"2020071612075356500_B187","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1046\/j.1365-2265.2001.01324.x","article-title":"Desmopressin stimulation test before and after pituitary surgery in patients with Cushing's disease","volume":"55","author":"Losa","year":"2001","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"9","key":"2020071612075356500_B188","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.1210\/jc.2009-0844","article-title":"Persistent adrenocorticotropin response to desmopressin in the early postoperative period predicts recurrence of Cushing's disease","volume":"94","author":"Losa","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2020071612075356500_B189","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1530\/eje.0.1430227","article-title":"Usefulness of the desmopressin test in the postoperative evaluation of patients with Cushing's disease","volume":"143","author":"Colombo","year":"2000","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"2020071612075356500_B190","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1530\/eje.0.1510727","article-title":"The desmopressin test as a predictive factor of outcome after pituitary surgery for Cushing's disease","volume":"151","author":"Val\u00e9ro","year":"2004","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2020071612075356500_B191","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1365-2265.2007.03168.x","article-title":"Role for postoperative cortisol response to desmopressin in predicting the risk for recurrent Cushing's disease","volume":"69","author":"Romanholi","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"2020071612075356500_B192","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/cen.12133","article-title":"Predicting late recurrence in surgically treated patients with Cushing's disease","volume":"79","author":"Barbot","year":"2013","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"2020071612075356500_B193","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s11102-005-0425-9","article-title":"Recurrence of Cushing's disease preceded by the reappearance of ACTH and cortisol responses to desmopressin test","volume":"7","author":"Dall'asta","year":"2004","journal-title":"Pituitary"},{"issue":"5","key":"2020071612075356500_B194","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1111\/j.1365-2265.2008.03406.x","article-title":"Desmopressin test may predict the risk of recurrence in Cushing's disease","volume":"70","author":"Ambrosi","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"7","key":"2020071612075356500_B195","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s00701-009-0297-2","article-title":"Microscope and endoscopic pituitary surgery","volume":"151","author":"Powell","year":"2009","journal-title":"Acta Neurochirurgica"},{"issue":"4","key":"2020071612075356500_B196","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1210\/jc.2011-3237","article-title":"Update on pituitary surgery","volume":"97","author":"Swearingen","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612075356500_B197","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1093\/neurosurgery\/16.CN_suppl_1.185","article-title":"Transphenoidal microsurgery of the normal and pathological pituitary","volume":"16","author":"Hardy","year":"1969","journal-title":"Clin Neurosurg"},{"issue":"2","key":"2020071612075356500_B198","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/00006123-199702000-00001","article-title":"Complications of transsphenoidal surgery: results of a national survey, review of the literature, and personal experience","volume":"40","author":"Ciric","year":"1997","journal-title":"Neurosurgery"},{"issue":"1","key":"2020071612075356500_B199","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/00006123-200207000-00023","article-title":"Transsphenoidal microsurgery","volume":"51","author":"Ciric","year":"2002","journal-title":"Neurosurgery"},{"key":"2020071612075356500_B200","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.1586\/14737140.6.9s.S75","article-title":"Transsphenoidal microsurgery: past, present and future","volume":"6","author":"Ciric","year":"2006","journal-title":"Expert Rev Anticancer Ther"},{"issue":"2","key":"2020071612075356500_B201","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1055\/s-2008-1052019","article-title":"Endoscopic endonasal transsphenoidal approach to the sella: towards functional endoscopic pituitary surgery (FEPS)","volume":"41","author":"Cappabianca","year":"1998","journal-title":"Minim Invasive Neurosurg"},{"issue":"4","key":"2020071612075356500_B202","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1055\/s-2002-36197","article-title":"Endoscopic endonasal transsphenoidal approach: outcome analysis of 100 consecutive procedures","volume":"45","author":"Cappabianca","year":"2002","journal-title":"Minim Invasive Neurosurg"},{"key":"2020071612075356500_B203","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1227\/01.NEU.0000137330.02549.0D","article-title":"Endoscopic endonasal transsphenoidal surgery","volume":"55","author":"Cappabianca","year":"2004","journal-title":"Neurosurgery"},{"key":"2020071612075356500_B204","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1159\/000095534","article-title":"The endoscopic versus the traditional approach in pituitary surgery","volume":"83","author":"Frank","year":"2006","journal-title":"Neuroendocrinology"},{"issue":"2","key":"2020071612075356500_B205","first-page":"175","article-title":"Purely endoscopic transsphenoidal surgery versus traditional microsurgery for resection of pituitary adenomas: systematic review","volume":"40","author":"Strychowsky","year":"2011","journal-title":"J Otolaryngol Head Neck Surg"},{"issue":"8","key":"2020071612075356500_B206","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1136\/jnnp-2012-303194","article-title":"Short-term outcome of endoscopic versus microscopic pituitary adenoma surgery: a systematic review and meta-analysis","volume":"84","author":"Ammirati","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2020071612075356500_B207","doi-asserted-by":"crossref","first-page":"S152","DOI":"10.1016\/j.wneu.2014.07.035","article-title":"The transition from microscopic to endoscopic transsphenoidal surgery: the experience at Brigham and Women's Hospital","volume":"82","author":"Laws","year":"2014","journal-title":"World Neurosurg"},{"issue":"2","key":"2020071612075356500_B208","first-page":"168","article-title":"Epidemiology and follow-up of Cushing's disease","volume":"62","author":"Cavagnini","year":"2001","journal-title":"Ann Endocrinol (Paris)"},{"issue":"2","key":"2020071612075356500_B209","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1210\/jcem-50-2-348","article-title":"Cushing's disease: management by transsphenoidal pituitary microsurgery","volume":"50","author":"Bigos","year":"1980","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2020071612075356500_B210","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1001\/archinte.1992.00400170067013","article-title":"Recurrent Cushing's disease after transsphenoidal surgery","volume":"152","author":"Tahir","year":"1992","journal-title":"Arch Intern Med"},{"issue":"4","key":"2020071612075356500_B211","doi-asserted-by":"crossref","first-page":"634","DOI":"10.3171\/jns.2004.100.4.0634","article-title":"Transsphenoidal surgery in Cushing disease: 10 years of experience in 34 consecutive cases","volume":"100","author":"Hoybye","year":"2004","journal-title":"J Neurosurg"},{"issue":"14","key":"2020071612075356500_B212","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1056\/NEJM198404053101405","article-title":"Treatment of Cushing's disease in childhood and adolescence by transsphenoidal microadenomectomy","volume":"310","author":"Styne","year":"1984","journal-title":"N Engl J Med"},{"key":"2020071612075356500_B213","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/978-3-7091-8813-2_17","article-title":"Neurosurgical treatment of Cushing's disease in children and adolescents","volume":"35","author":"Buchfelder","year":"1985","journal-title":"Acta Neurochir Suppl (Wien)"},{"issue":"4","key":"2020071612075356500_B214","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1227\/00006123-199110000-00004","article-title":"Pediatric pituitary tumors","volume":"29","author":"Haddad","year":"1991","journal-title":"Neurosurgery"},{"issue":"2","key":"2020071612075356500_B215","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3171\/jns.1994.80.2.0209","article-title":"Pituitary adenomas in childhood and adolescence. Results of transsphenoidal surgery","volume":"80","author":"Partington","year":"1994","journal-title":"J Neurosurg"},{"issue":"10","key":"2020071612075356500_B216","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1056\/NEJM199409083311002","article-title":"Cushing's syndrome in children and adolescents. Presentation, diagnosis, and therapy","volume":"331","author":"Magiakou","year":"1994","journal-title":"N Engl J Med"},{"issue":"2","key":"2020071612075356500_B217","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1227\/00006123-199402000-00001","article-title":"Transsphenoidal surgery for pituitary adenomas in children","volume":"34","author":"Dyer","year":"1994","journal-title":"Neurosurgery"},{"issue":"1","key":"2020071612075356500_B218","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1365-2265.1995.tb01888.x","article-title":"Investigation, management and therapeutic outcome in 12 cases of childhood and adolescent Cushing's syndrome","volume":"43","author":"Weber","year":"1995","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"8","key":"2020071612075356500_B219","first-page":"2475","article-title":"Long term follow-up of transsphenoidal surgery for the treatment of Cushing's disease in childhood","volume":"80","author":"Leinung","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2020071612075356500_B220","first-page":"3196","article-title":"Long-term outcome in children and adolescents after transsphenoidal surgery for Cushing's disease","volume":"82","author":"Devoe","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2020071612075356500_B221","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1136\/adc.76.5.398","article-title":"Transsphenoidal surgery for pituitary tumours","volume":"76","author":"Massoud","year":"1997","journal-title":"Arch Dis Child"},{"key":"2020071612075356500_B222","first-page":"24","article-title":"Cushing's disease in childhood: presentation, investigation, treatment and long-term outcome","volume":"55","author":"Savage","year":"2001","journal-title":"Horm Res"},{"issue":"2","key":"2020071612075356500_B223","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1227\/01.NEU.0000166580.94215.53","article-title":"Cushing's disease in children and adolescents: 20 years of experience in a single neurosurgical center","volume":"57","author":"Joshi","year":"2005","journal-title":"Neurosurgery"},{"key":"2020071612075356500_B224","first-page":"413","article-title":"Single-center experience with pediatric Cushing's disease","volume":"103","author":"Kanter","year":"2005","journal-title":"J Neurosurg"},{"issue":"6","key":"2020071612075356500_B225","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1530\/eje.1.01921","article-title":"Factors influencing cure by transsphenoidal selective adenomectomy in paediatric Cushing's disease","volume":"152","author":"Storr","year":"2005","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"2020071612075356500_B226","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s00381-006-0259-4","article-title":"Pituitary tumors in children: clinical analysis of 21 cases","volume":"23","author":"Mehrazin","year":"2007","journal-title":"Childs Nerv Syst"},{"issue":"3","key":"2020071612075356500_B227","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.surneu.2006.05.067","article-title":"Surgical management of pediatric Cushing's disease","volume":"67","author":"Das","year":"2007","journal-title":"Surg Neurol"},{"issue":"3","key":"2020071612075356500_B228","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1530\/EJE-09-0509","article-title":"Diagnosis, management and therapeutic outcome in prepubertal Cushing's disease","volume":"162","author":"Dias","year":"2010","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2020071612075356500_B229","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1590\/S0004-27302010000100004","article-title":"Surgical management of pediatric Cushing's disease: an analysis of 15 consecutive cases at a specialized neurosurgical center","volume":"54","author":"Oliveira","year":"2010","journal-title":"Arq Bras Endocrinol Metabol"},{"issue":"3","key":"2020071612075356500_B230","doi-asserted-by":"crossref","first-page":"369","DOI":"10.4158\/EP10143.OR","article-title":"Cushing disease in children and adolescents: twenty years' experience in a tertiary care center in India","volume":"17","author":"Shah","year":"2011","journal-title":"Endocr Pract"},{"issue":"3","key":"2020071612075356500_B231","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1210\/jc.2012-3604","article-title":"Outcome of surgical treatment of 200 children with Cushing's disease","volume":"98","author":"Lonser","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2020071612075356500_B232","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/cen.12275","article-title":"Endonasal endoscopic transsphenoidal pituitary surgery: early experience and outcome in paediatric Cushing's disease","volume":"80","author":"Storr","year":"2014","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"2020071612075356500_B233","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1530\/EJE-10-1120","article-title":"Comparisons in the epidemiology, diagnostic features and cure rate by transsphenoidal surgery between paediatric and adult-onset Cushing's disease","volume":"164","author":"Storr","year":"2011","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"2020071612075356500_B234","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1210\/jc.2002-021518","article-title":"Gender-related differences in the presentation and course of Cushing's disease","volume":"88","author":"Pecori Giraldi","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2020071612075356500_B235","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.3171\/jns.2002.97.6.1343","article-title":"Basis of persistent and recurrent Cushing disease: an analysis of findings at repeated pituitary surgery","volume":"97","author":"Dickerman","year":"2002","journal-title":"J Neurosurg"},{"issue":"2","key":"2020071612075356500_B236","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1210\/jcem-54-2-286","article-title":"Adrenocorticotropin-secreting pituitary adenomas originate from the anterior or the intermediate lobe in Cushing's disease: differences in the regulation of hormone secretion","volume":"54","author":"Lamberts","year":"1982","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612075356500_B237","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.wneu.2011.06.033","article-title":"Surgical management and outcomes in patients with Cushing disease with negative pituitary magnetic resonance imaging","volume":"77","author":"Yamada","year":"2012","journal-title":"World Neurosurg"},{"issue":"5","key":"2020071612075356500_B238","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1227\/01.neu.0000325862.83961.12","article-title":"Pure endoscopic endonasal approach for pituitary adenomas: early surgical results in 200 patients and comparison with previous microsurgical series","volume":"62","author":"Dehdashti","year":"2008","journal-title":"Neurosurgery"},{"key":"2020071612075356500_B239","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1159\/000091580","article-title":"Treatment of Cushing's disease: a retrospective clinical study of the latest 100 cases","volume":"34","author":"Hofmann","year":"2006","journal-title":"Front Horm Res"},{"issue":"9","key":"2020071612075356500_B240","doi-asserted-by":"crossref","first-page":"3383","DOI":"10.1210\/jc.2007-0208","article-title":"Outcomes and management of patients with Cushing's disease without pathological confirmation of tumor resection after transsphenoidal surgery","volume":"92","author":"Pouratian","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2020071612075356500_B241","first-page":"33","article-title":"Results of transsphenoidal surgery for Cushing's disease in patients with no histologically confirmed tumor","volume":"47","author":"Sheehan","year":"2000","journal-title":"Neurosurgery"},{"issue":"2","key":"2020071612075356500_B242","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1227\/01.NEU.0000223437.51435.6E","article-title":"Pathobiology of pituitary adenomas and carcinomas","volume":"59","author":"Scheithauer","year":"2006","journal-title":"Neurosurgery"},{"issue":"1","key":"2020071612075356500_B243","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0090-3019(99)00159-7","article-title":"Absence of peritumoral Crooke's change is associated with recurrence in surgically treated Cushing's disease","volume":"53","author":"Hague","year":"2000","journal-title":"Surg Neurol"},{"issue":"1","key":"2020071612075356500_B244","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0300-595X(77)80055-8","article-title":"Histopathology of the anterior pituitary","volume":"6","author":"Doniach","year":"1977","journal-title":"Clin Endocrinol Metab"},{"issue":"1","key":"2020071612075356500_B245","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/eci.12010","article-title":"ACTH-secreting Crooke cell carcinoma of the pituitary","volume":"43","author":"Kov\u00e1cs","year":"2013","journal-title":"Eur J Clin Invest"},{"key":"2020071612075356500_B246","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/BF01407130","article-title":"Massive Crooke's hyalinization in corticotroph cell adenomas of the human pituitary. A histological, immunocytological, and electron microscopic study of three cases","volume":"58","author":"Felix","year":"1981","journal-title":"Acta Neurochir (Wien)"},{"issue":"10","key":"2020071612075356500_B247","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1097\/00000478-200310000-00005","article-title":"Crooke's cell adenoma of the pituitary: an aggressive variant of corticotroph adenoma","volume":"27","author":"George","year":"2003","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"2020071612075356500_B248","doi-asserted-by":"crossref","first-page":"4709","DOI":"10.1210\/jc.2003-030461","article-title":"Transsphenoidal surgery for pituitary tumors in the United States, 1996\u20132000: mortality, morbidity, and the effects of hospital and surgeon volume","volume":"88","author":"Barker","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612075356500_B249","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1007\/BF01411120","article-title":"Endoscopy assisted transsphenoidal surgery for pituitary adenoma. Technical note","volume":"138","author":"Jho","year":"1996","journal-title":"Acta Neurochir (Wien)"},{"issue":"2","key":"2020071612075356500_B250","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1023\/A:1012969719503","article-title":"Endoscopic transsphenoidal surgery","volume":"54","author":"Jho","year":"2001","journal-title":"J Neurooncol"},{"issue":"2","key":"2020071612075356500_B251","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3171\/jns.2002.97.2.0293","article-title":"Surgical complications associated with the endoscopic endonasal transsphenoidal approach for pituitary adenomas","volume":"97","author":"Cappabianca","year":"2002","journal-title":"J Neurosurg"},{"issue":"5","key":"2020071612075356500_B252","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1530\/eje.1.02133","article-title":"Transsphenoidal pituitary surgery via the endoscopic technique: results in 35 consecutive patients with Cushing's disease","volume":"154","author":"Netea-Maier","year":"2006","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"2020071612075356500_B253","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S0889-8529(18)30467-5","article-title":"Pituitary surgery","volume":"16","author":"Laws","year":"1987","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"4","key":"2020071612075356500_B254","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.wneu.2010.02.069","article-title":"Intraoperative conversion from endoscopic to microscopic approach for the management of sellar pathology: incidence and rationale in a contemporary series","volume":"73","author":"Zada","year":"2010","journal-title":"World Neurosurg"},{"issue":"4","key":"2020071612075356500_B255","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s11102-012-0453-1","article-title":"Post-operative diabetes insipidus after endoscopic transsphenoidal surgery","volume":"16","author":"Schreckinger","year":"2013","journal-title":"Pituitary"},{"issue":"2","key":"2020071612075356500_B256","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3171\/jns.1995.83.2.0363","article-title":"Delayed hyponatremia after transsphenoidal surgery for pituitary adenoma. Report of nine cases","volume":"83","author":"Kelly","year":"1995","journal-title":"J Neurosurg"},{"issue":"11","key":"2020071612075356500_B257","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1017\/S0022215100114288","article-title":"Early inappropriate secretion of antidiuretic hormone after trans-sphenoidal pituitary adenomectomy","volume":"104","author":"Murty","year":"1990","journal-title":"J Laryngol Otol"},{"issue":"6","key":"2020071612075356500_B258","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1159\/000126310","article-title":"Transient hyponatremia after damage to the neurohypophyseal tracts","volume":"56","author":"Ultmann","year":"1992","journal-title":"Neuroendocrinology"},{"issue":"3","key":"2020071612075356500_B259","doi-asserted-by":"crossref","first-page":"E7","DOI":"10.3171\/foc.2007.23.3.9","article-title":"National trends, complications, and outcomes following transsphenoidal surgery for Cushing's disease from 1993 to 2002","volume":"23","author":"Patil","year":"2007","journal-title":"Neurosurg Focus"},{"issue":"4","key":"2020071612075356500_B260","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.nec.2012.06.001","article-title":"Hypopituitarism and central diabetes insipidus: perioperative diagnosis and management","volume":"23","author":"Devin","year":"2012","journal-title":"Neurosurg Clin N Am"},{"issue":"1","key":"2020071612075356500_B261","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1046\/j.1365-2265.1999.00738.x","article-title":"Growth hormone status following treatment for Cushing's syndrome","volume":"51","author":"Hughes","year":"1999","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"2020071612075356500_B262","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/S0022-3476(97)70041-6","article-title":"Thyroid function in children with Cushing's disease before and after transsphenoidal surgery","volume":"131","author":"Stratakis","year":"1997","journal-title":"J Pediatr"},{"issue":"9935","key":"2020071612075356500_B263","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1016\/S0140-6736(13)61684-0","article-title":"Adrenal insufficiency","volume":"383","author":"Charmandari","year":"2014","journal-title":"Lancet"},{"issue":"1","key":"2020071612075356500_B264","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1017\/S031716710012075X","article-title":"Management of Cushing's disease after failed surgery\u2013a review","volume":"38","author":"McLaughlin","year":"2011","journal-title":"Can J Neurol Sci"},{"issue":"3","key":"2020071612075356500_B265","doi-asserted-by":"crossref","first-page":"E8","DOI":"10.3171\/foc.2007.23.3.10","article-title":"Treatment options for Cushing disease after unsuccessful transsphenoidal surgery","volume":"23","author":"Liu","year":"2007","journal-title":"Neurosurg Focus"},{"issue":"3","key":"2020071612075356500_B266","doi-asserted-by":"crossref","first-page":"E5","DOI":"10.3171\/foc.2007.23.3.7","article-title":"Transsphenoidal surgery for Cushing's disease: a review of success rates, remission predictors, management of failed surgery, and Nelson's syndrome","volume":"23","author":"Kelly","year":"2007","journal-title":"Neurosurg Focus"},{"issue":"10","key":"2020071612075356500_B267","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/ncpendmet0947","article-title":"Management of recurrent and refractory Cushing disease","volume":"4","author":"Aghi","year":"2008","journal-title":"Nat Clin Pract Endocrinol Metab"},{"issue":"3","key":"2020071612075356500_B268","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s11060-009-9888-2","article-title":"An approach to the management of patients with residual Cushing's disease","volume":"94","author":"Blevins","year":"2009","journal-title":"J Neurooncol"},{"issue":"1","key":"2020071612075356500_B269","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jocn.2010.05.001","article-title":"Management of recurrent Cushing's disease","volume":"18","author":"Liubinas","year":"2011","journal-title":"J Clin Neurosci"},{"issue":"4","key":"2020071612075356500_B270","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1210\/jc.2012-3200","article-title":"Approach to Cushing's disease patients with persistent\/recurrent hypercortisolism after pituitary surgery","volume":"98","author":"Bertagna","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2020071612075356500_B271","doi-asserted-by":"crossref","first-page":"520","DOI":"10.3171\/jns.1989.71.4.0520","article-title":"Repeat transsphenoidal surgery for Cushing's disease","volume":"71","author":"Friedman","year":"1989","journal-title":"J Neurosurg"},{"issue":"6","key":"2020071612075356500_B272","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.3171\/jns.2005.102.6.1004","article-title":"Repeated transsphenoidal surgery to treat recurrent or residual pituitary adenoma","volume":"102","author":"Benveniste","year":"2005","journal-title":"J Neurosurg"},{"issue":"6","key":"2020071612075356500_B273","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1227\/01.NEU.0000215945.26764.92","article-title":"Surgical treatment of recurrent Cushing's disease","volume":"58","author":"Hofmann","year":"2006","journal-title":"Neurosurgery"},{"key":"2020071612075356500_B274","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1227\/01.NEU.0000313117.35824.9F","article-title":"Outcomes after repeat transsphenoidal surgery for recurrent Cushing's disease","volume":"63","author":"Patil","year":"2008","journal-title":"Neurosurgery"},{"issue":"2","key":"2020071612075356500_B275","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1365-2265.2008.03334.x","article-title":"Repeated transsphenoidal pituitary surgery (TS) via the endoscopic technique: a good therapeutic option for recurrent or persistent Cushing's disease (CD)","volume":"70","author":"Wagenmakers","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"2020071612075356500_B276","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.endonu.2013.10.008","article-title":"Results of repeated transsphenoidal surgery in Cushing's disease. Long-term follow-up","volume":"61","author":"Valderr\u00e1bano","year":"2014","journal-title":"Endocrinol Nutr"},{"issue":"5","key":"2020071612075356500_B277","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.3171\/foc.2003.14.5.12","article-title":"Hypophysial transposition (hypophysopexy) for radiosurgical treatment of pituitary tumors involving the cavernous sinus. Technical note","volume":"14","author":"Liu","year":"2003","journal-title":"Neurosurg Focus"},{"issue":"2","key":"2020071612075356500_B278","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s11102-014-0615-4","article-title":"Update on radiation therapy in patients with Cushing's disease","volume":"18","author":"Tritos","year":"2015","journal-title":"Pituitary"},{"issue":"3","key":"2020071612075356500_B279","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1023\/A:1023365200437","article-title":"Radiation therapy for Cushing's disease: a review","volume":"5","author":"Mahmoud-Ahmed","year":"2002","journal-title":"Pituitary"},{"issue":"1","key":"2020071612075356500_B280","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s11102-008-0117-3","article-title":"Cushing's disease: radiation therapy","volume":"12","author":"Vance","year":"2009","journal-title":"Pituitary"},{"key":"2020071612075356500_B281","first-page":"E5","article-title":"Stereotactic radiosurgery for Cushing's disease","volume":"16","author":"Hentshel","year":"2004","journal-title":"Neurosurg Focus"},{"issue":"8","key":"2020071612075356500_B282","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1590\/S0004-27302007000800024","article-title":"Radiotherapy and radiosurgery for Cushing's disease","volume":"51","author":"Minniti","year":"2007","journal-title":"Arq Bras Endocrinol Metabol"},{"issue":"1","key":"2020071612075356500_B283","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ecl.2007.10.005","article-title":"Radiotherapy for pituitary adenomas","volume":"37","author":"Brada","year":"2008","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"2","key":"2020071612075356500_B284","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s11154-008-9106-0","article-title":"Modern techniques for pituitary radiotherapy","volume":"10","author":"Minniti","year":"2009","journal-title":"Rev Endocr Metab Disord"},{"issue":"4","key":"2020071612075356500_B285","doi-asserted-by":"crossref","first-page":"678","DOI":"10.3171\/jns.2005.102.4.0678","article-title":"Stereotactic radiosurgery for pituitary adenomas: an intermediate review of its safety, efficacy, and role in the neurosurgical treatment armamentarium","volume":"102","author":"Sheehan","year":"2005","journal-title":"J Neurosurg"},{"issue":"4","key":"2020071612075356500_B286","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1097\/MED.0b013e32833ab069","article-title":"Radiation therapy and stereotactic radiosurgery for the treatment of Cushing's disease: an evidence-based review","volume":"17","author":"Starke","year":"2010","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"7","key":"2020071612075356500_B287","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1210\/jc.2011-0251","article-title":"Radiation therapy in the management of pituitary adenomas","volume":"96","author":"Loeffler","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2020071612075356500_B288","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s11060-013-1262-8","article-title":"Treatment paradigms for pituitary adenomas: defining the roles of radiosurgery and radiation therapy","volume":"117","author":"Ding","year":"2014","journal-title":"J Neurooncol"},{"issue":"6","key":"2020071612075356500_B289","doi-asserted-by":"crossref","first-page":"E14","DOI":"10.3171\/FOC-07\/12\/E14","article-title":"Stereotactic radiosurgery for Cushing disease: a review","volume":"23","author":"Oyesiku","year":"2007","journal-title":"Neurosurg Focus"},{"issue":"3","key":"2020071612075356500_B290","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s11060-009-9832-5","article-title":"Stereotactic radiosurgery for pituitary adenomas: a comprehensive review of indications, techniques and long-term results using the gamma knife","volume":"92","author":"Jagannathan","year":"2009","journal-title":"J Neurooncol"},{"key":"2020071612075356500_B291","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1159\/000099553","article-title":"Heavy-charged-particle radiosurgery of the pituitary gland: clinical results of 840 patients","volume":"57","author":"Levy","year":"1991","journal-title":"Stereotact Funct Neurosurg"},{"issue":"2","key":"2020071612075356500_B292","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1210\/jc.2007-1220","article-title":"Proton stereotactic radiotherapy for persistent adrenocorticotropin-producing adenomas","volume":"93","author":"Petit","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2020071612075356500_B293","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.ijrobp.2014.06.068","article-title":"Outcomes of proton therapy for patients with functional pituitary adenomas","volume":"90","author":"Wattson","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2020071612075356500_B294","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/0360-3016(90)90326-F","article-title":"Treatment planning for gamma knife radiosurgery with multiple isocenters","volume":"18","author":"Flickinger","year":"1990","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"2020071612075356500_B295","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S1042-3680(18)30689-2","article-title":"Gamma knife surgery for sellar and suprasellar tumors","volume":"3","author":"Stephanian","year":"1992","journal-title":"Neurosurg Clin N Am"},{"issue":"2","key":"2020071612075356500_B296","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0360-3016(93)90230-S","article-title":"Tolerance of cranial nerves of the cavernous sinus to radiosurgery","volume":"27","author":"Tishler","year":"1993","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"2020071612075356500_B297","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3171\/jns.1998.88.1.0043","article-title":"Dose-response tolerance of the visual pathways and cranial nerves of the cavernous sinus to stereotactic radiosurgery","volume":"88","author":"Leber","year":"1998","journal-title":"J Neurosurg"},{"issue":"5","key":"2020071612075356500_B298","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1056\/NEJM197107292850501","article-title":"Results of treatment in 108 patients with Cushing's syndrome","volume":"285","author":"Orth","year":"1971","journal-title":"N Engl J Med"},{"issue":"9","key":"2020071612075356500_B299","first-page":"860","article-title":"External irradiation of the hypophysis for Cushing's disease","volume":"107","author":"Edmonds","year":"1972","journal-title":"Can Med Assoc J"},{"issue":"2","key":"2020071612075356500_B300","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0009-9260(79)80135-X","article-title":"Treatment of Cushing's disease with adrenal blocking drugs and megavoltage therapy to the pituitary","volume":"30","author":"Ross","year":"1979","journal-title":"Clin Radiol"},{"issue":"6446","key":"2020071612075356500_B301","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1136\/bmj.289.6446.643","article-title":"Treatment of Cushing's disease with low dose radiation therapy","volume":"289","author":"Ahmed","year":"1984","journal-title":"Br Med J Clin Res Ed"},{"issue":"2","key":"2020071612075356500_B302","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1365-2265.1985.tb01078.x","article-title":"Pituitary function following megavoltage therapy for Cushing's disease: long term follow up","volume":"22","author":"Sharpe","year":"1985","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"2020071612075356500_B303","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1365-2265.1989.tb01255.x","article-title":"Megavoltage pituitary irradiation in the management of Cushing's disease and Nelson's syndrome: long-term follow-up","volume":"31","author":"Howlett","year":"1989","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"2020071612075356500_B304","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1365-2265.1990.tb03883.x","article-title":"Long-term follow-up of low-dose external pituitary irradiation for Cushing's disease","volume":"33","author":"Littley","year":"1990","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"2020071612075356500_B305","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1530\/acta.0.1250470","article-title":"Results of external pituitary irradiation after unsuccessful transsphenoidal surgery in Cushing's disease","volume":"125","author":"Vicente","year":"1991","journal-title":"Acta Endocrinol (Copenh)"},{"issue":"1","key":"2020071612075356500_B306","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/00000421-199102000-00005","article-title":"Radiation therapy of pituitary tumors: results in 95 cases","volume":"14","author":"Tran","year":"1991","journal-title":"Am J Clin Oncol"},{"issue":"3","key":"2020071612075356500_B307","first-page":"935","article-title":"Long term follow-up of Cushing's disease treated with reserpine and pituitary irradiation","volume":"75","author":"Murayama","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2020071612075356500_B308","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0360-3016(95)00071-6","article-title":"External radiotherapy of pituitary adenomas","volume":"33","author":"Zierhut","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"2020071612075356500_B309","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0167-8140(96)91807-1","article-title":"Role of radiation therapy in clinical hormonally-active pituitary adenomas","volume":"41","author":"Tsang","year":"1996","journal-title":"Radiother Oncol"},{"issue":"3","key":"2020071612075356500_B310","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1056\/NEJM199701163360303","article-title":"The long-term outcome of pituitary irradiation after unsuccessful transsphenoidal surgery in Cushing's disease","volume":"336","author":"Estrada","year":"1997","journal-title":"N Engl J Med"},{"issue":"1","key":"2020071612075356500_B311","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s11060-007-9344-0","article-title":"Long-term follow-up results of postoperative radiation therapy for Cushing's disease","volume":"84","author":"Minniti","year":"2007","journal-title":"J Neurooncol"},{"issue":"3","key":"2020071612075356500_B312","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/0360-3016(92)90941-A","article-title":"Radiation therapy for pituitary adenoma: treatment outcome and prognostic factors","volume":"30","author":"Tsang","year":"1994","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"18","key":"2020071612075356500_B313","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1056\/NEJM197711032971801","article-title":"Results of treating childhood Cushing's disease with pituitary irradiation","volume":"297","author":"Jennings","year":"1977","journal-title":"N Engl J Med"},{"issue":"3","key":"2020071612075356500_B314","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1651-2227.1986.tb10219.x","article-title":"Treatment of Cushing's disease in childhood and adolescence by stereotactic pituitary irradiation","volume":"75","author":"Thoren","year":"1986","journal-title":"Acta Paediatr Scand"},{"issue":"6","key":"2020071612075356500_B315","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1097\/00000421-198812000-00001","article-title":"Long-term results of radiotherapy in the treatment of pituitary adenomas in children and adolescents","volume":"11","author":"Grigsby","year":"1988","journal-title":"Am J Clin Oncol"},{"issue":"1","key":"2020071612075356500_B316","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1210\/jc.2002-021032","article-title":"Clinical and endocrine responses to pituitary radiotherapy in pediatric Cushing's disease: an effective second-line treatment","volume":"88","author":"Storr","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2020071612075356500_B317","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jocn.2004.10.003","article-title":"Pediatric pituitary adenoma: a series of 42 patients","volume":"12","author":"Pandey","year":"2005","journal-title":"J Clin Neurosci"},{"issue":"3","key":"2020071612075356500_B318","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1530\/acta.0.1120310","article-title":"Long-term results of stereotactic radiosurgery to the pituitary gland in Cushing's disease","volume":"112","author":"Degerblad","year":"1986","journal-title":"Acta Endocrinol (Copenh)"},{"key":"2020071612075356500_B319","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1159\/000100657","article-title":"The effects of Gamma Knife surgery of pituitary adenomas on tumor growth and endocrinopathies. Stereotact","volume":"61","author":"Ganz","year":"1993","journal-title":"Funct Neurosurg"},{"key":"2020071612075356500_B320","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1159\/000056413","article-title":"Pituitary tumors and gamma knife surgery. Clinical experience with more than two years of follow-up","volume":"70","author":"Martinez","year":"1998","journal-title":"Stereotact Funct Neurosurg"},{"key":"2020071612075356500_B321","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1159\/000056412","article-title":"Four years' experiences in the treatment of pituitary adenomas with gamma knife radiosurgery","volume":"70","author":"Lim","year":"1998","journal-title":"Stereotact Funct Neurosurg"},{"issue":"3","key":"2020071612075356500_B322","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0360-3016(98)00256-9","article-title":"Initial clinical results of LINAC-based stereotactic radiosurgery and stereotactic radiotherapy for pituitary adenomas","volume":"42","author":"Mitsumori","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"2020071612075356500_B323","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s007010050121","article-title":"Gamma-knife surgery for secreting pituitary adenomas","volume":"140","author":"Morange-Ramos","year":"1998","journal-title":"Acta Neurochir (Wien)"},{"key":"2020071612075356500_B324","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1159\/000056446","article-title":"Gamma Knife radiosurgery for pituitary adenomas","volume":"72","author":"Hayashi","year":"1999","journal-title":"Stereotact Funct Neurosurg"},{"key":"2020071612075356500_B325","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1159\/000056448","article-title":"Pituitary adenomas treated by microsurgery with or without Gamma Knife surgery: experience in 122 cases","volume":"72","author":"Inoue","year":"1999","journal-title":"Stereotact Funct Neurosurg"},{"key":"2020071612075356500_B326","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1159\/000056444","article-title":"A six year experience with the postoperative radiosurgical management of pituitary adenomas","volume":"72","author":"Mokry","year":"1999","journal-title":"Stereotact Funct Neurosurg"},{"issue":"2","key":"2020071612075356500_B327","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1042-3680(18)30198-0","article-title":"Radiosurgery for pituitary tumors and craniopharyngiomas","volume":"10","author":"Laws","year":"1999","journal-title":"Neurosurg Clin N Am"},{"issue":"5","key":"2020071612075356500_B328","doi-asserted-by":"crossref","first-page":"738","DOI":"10.3171\/jns.2000.93.5.0738","article-title":"Radiosurgery for Cushing's disease after failed transsphenoidal surgery","volume":"93","author":"Sheehan","year":"2000","journal-title":"J Neurosurg"},{"key":"2020071612075356500_B329","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3171\/jns.2000.93.supplement_3.0002","article-title":"Stereotactic radiosurgery for pituitary adenoma invading the cavernous sinus","volume":"93","author":"Shin","year":"2000","journal-title":"J Neurosurg"},{"key":"2020071612075356500_B330","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3171\/jns.2000.93.supplement_3.0019","article-title":"Gamma knife radiosurgery for pituitary adenomas","volume":"93","author":"Izawa","year":"2000","journal-title":"J Neurosurg"},{"issue":"2\u20133","key":"2020071612075356500_B331","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000048393","article-title":"Gamma Knife radiosurgery as a primary surgical treatment for hypersecreting pituitary adenomas","volume":"75","author":"Zhang","year":"2000","journal-title":"Stereotact Funct Neurosurg"},{"issue":"2","key":"2020071612075356500_B332","first-page":"284","article-title":"Adrenocorticotropic hormone-producing pituitary tumors: 12- to 22-year follow-up after treatment with stereotactic radiosurgery","volume":"49","author":"Hoybye","year":"2001","journal-title":"Neurosurgery"},{"key":"2020071612075356500_B333","doi-asserted-by":"crossref","first-page":"422","DOI":"10.3171\/jns.2002.97.supplement_5.0422","article-title":"Gamma knife radiosurgery in the treatment of Cushing disease: long-term results","volume":"97","author":"Kobayashi","year":"2002","journal-title":"J Neurosurg"},{"issue":"3","key":"2020071612075356500_B334","doi-asserted-by":"crossref","first-page":"525","DOI":"10.3171\/jns.2002.97.3.0525","article-title":"Results of stereotactic radiosurgery in patients with hormone-producing pituitary adenomas: factors associated with endocrine normalization","volume":"97","author":"Pollock","year":"2002","journal-title":"J Neurosurg"},{"issue":"6","key":"2020071612075356500_B335","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1055\/s-2003-812497","article-title":"LINAC radiosurgery in recurrent Cushing's disease after transsphenoidal surgery: a series of 5 cases","volume":"46","author":"Wong","year":"2003","journal-title":"Minim Invasive Neurosurg"},{"issue":"1","key":"2020071612075356500_B336","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1227\/01.NEU.0000068702.00330.47","article-title":"Gamma knife radiosurgery for pituitary adenoma: early results","volume":"53","author":"Petrovich","year":"2003","journal-title":"Neurosurgery"},{"issue":"4","key":"2020071612075356500_B337","doi-asserted-by":"crossref","first-page":"602","DOI":"10.3349\/ymj.2003.44.4.602","article-title":"Radiological and hormonal responses of functioning pituitary adenomas after gamma knife radiosurgery","volume":"44","author":"Choi","year":"2003","journal-title":"Yonsei Med J"},{"issue":"5\u20136","key":"2020071612075356500_B338","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1159\/000083476","article-title":"The efficacy of linear accelerator radiosurgery in the management of patients with Cushing's disease","volume":"82","author":"Devin","year":"2004","journal-title":"Stereotact Funct Neurosurg"},{"issue":"2","key":"2020071612075356500_B339","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ijrobp.2004.09.058","article-title":"Treatment of pituitary adenomas by fractionated stereotactic radiotherapy: a prospective study of 110 patients","volume":"62","author":"Colin","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"2020071612075356500_B340","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1055\/s-2004-830261","article-title":"Image-guided stereotactic radiosurgery with the CyberKnife for pituitary adenomas","volume":"48","author":"Kajiwara","year":"2005","journal-title":"Minim Invasive Neurosurg"},{"issue":"4","key":"2020071612075356500_B341","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1002\/cncr.22860","article-title":"The efficacy of fractionated radiotherapy and stereotactic radiosurgery for pituitary adenomas: long-term results of 125 consecutive patients treated in a single institution","volume":"110","author":"Kong","year":"2007","journal-title":"Cancer"},{"issue":"6","key":"2020071612075356500_B342","doi-asserted-by":"crossref","first-page":"980","DOI":"10.3171\/jns.2007.106.6.980","article-title":"Gamma Knife surgery for Cushing's disease","volume":"106","author":"Jagannathan","year":"2007","journal-title":"J Neurosurg"},{"issue":"1","key":"2020071612075356500_B343","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1530\/eje.1.02323","article-title":"Gamma knife radiosurgery is a successful adjunctive treatment in Cushing's disease","volume":"156","author":"Castinetti","year":"2007","journal-title":"Eur J Endocrinol"},{"issue":"10","key":"2020071612075356500_B344","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1111\/j.1445-5994.2012.02903.x","article-title":"Stereotactic radiosurgery for treatment of Cushing disease: an Australian experience","volume":"42","author":"Wein","year":"2012","journal-title":"Intern Med J"},{"issue":"4","key":"2020071612075356500_B345","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1017\/S0317167100014645","article-title":"Gamma knife in the treatment of pituitary adenomas: results of a single center","volume":"40","author":"Zeiler","year":"2013","journal-title":"Can J Neurol Sci"},{"issue":"6","key":"2020071612075356500_B346","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.3171\/2013.7.JNS13217","article-title":"Results of gamma knife surgery for Cushing's disease","volume":"119","author":"Sheehan","year":"2013","journal-title":"J Neurosurg"},{"issue":"1\u20132","key":"2020071612075356500_B347","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.wneu.2013.01.127","article-title":"Efficacy and safety of higher dose stereotactic radiosurgery for functional pituitary adenomas: a preliminary report","volume":"82","author":"Grant","year":"2014","journal-title":"World Neurosurg"},{"issue":"1","key":"2020071612075356500_B348","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s11102-013-0466-4","article-title":"Encouraging efficacy of modern conformal fractionated radiotherapy in patients with uncured Cushing's disease","volume":"17","author":"Budyal","year":"2014","journal-title":"Pituitary"},{"issue":"1","key":"2020071612075356500_B349","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jocn.2013.04.007","article-title":"Cushing's disease: a single centre's experience using the linear accelerator (LINAC) for stereotactic radiosurgery and fractionated stereotactic radiotherapy","volume":"21","author":"Wilson","year":"2014","journal-title":"J Clin Neurosci"},{"key":"2020071612075356500_B350","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1159\/000056447","article-title":"Gamma Knife radiosurgery for functioning pituitary microadenoma","volume":"72","author":"Kim","year":"1999","journal-title":"Stereotact Funct Neurosurg"},{"key":"2020071612075356500_B351","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3171\/jns.2002.97.supplement_5.0415","article-title":"Effects of gamma knife radiosurgery of pituitary adenomas on pituitary function","volume":"97","author":"Feigl","year":"2002","journal-title":"J Neurosurg"},{"issue":"3","key":"2020071612075356500_B352","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1210\/jcem.85.3.6464","article-title":"Octreotide may act as a radioprotective agent in acromegaly","volume":"85","author":"Landolt","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612075356500_B353","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3171\/jns.2000.93.supplement_3.0014","article-title":"Gamma knife radiosurgery for prolactinomas","volume":"93","author":"Landolt","year":"2000","journal-title":"J Neurosurg"},{"key":"2020071612075356500_B354","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s11102-006-6042-4","article-title":"Hypopituitarism as a consequence of brain tumours and radiotherapy","volume":"8","author":"Darzy","year":"2005","journal-title":"Pituitary"},{"key":"2020071612075356500_B355","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3171\/2010.8.GKS10959","article-title":"Pituitary insufficiency as a side effect after radiosurgery for pituitary adenomas: the role of the hypothalamus","volume":"113","author":"Feigl","year":"2010","journal-title":"J Neurosurg"},{"issue":"1","key":"2020071612075356500_B356","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1023\/A:1006450024305","article-title":"Long-term results of radiation therapy for pituitary adenoma","volume":"47","author":"Kokubo","year":"2000","journal-title":"J Neurooncol"},{"issue":"3","key":"2020071612075356500_B357","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1365-2265.1989.tb01260.x","article-title":"Radiation-induced hypopituitarism is dose-dependent","volume":"31","author":"Littley","year":"1989","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"2020071612075356500_B358","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/S0360-3016(00)01387-0","article-title":"Hypothalamic\/pituitary function following high-dose conformal radiotherapy to the base of skull: demonstration of a dose-effect relationship using dose-volume histogram analysis","volume":"49","author":"Pai","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"2020071612075356500_B359","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1227\/01.NEU.0000370978.31405.A9","article-title":"Factors associated with endocrine deficits after stereotactic radiosurgery of pituitary adenomas","volume":"67","author":"Leenstra","year":"2010","journal-title":"Neurosurgery"},{"issue":"4","key":"2020071612075356500_B360","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1227\/NEU.0b013e3182846e44","article-title":"Hypopituitarism after stereotactic radiosurgery for pituitary adenomas","volume":"72","author":"Xu","year":"2013","journal-title":"Neurosurgery"},{"issue":"4","key":"2020071612075356500_B361","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1046\/j.1365-2796.2003.01125.x","article-title":"The hypothalamus-pituitary function after pituitary stereotactic radiosurgery: evaluation of growth hormone deficiency","volume":"253","author":"Degerblad","year":"2003","journal-title":"J Intern Med"},{"issue":"1","key":"2020071612075356500_B362","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1148\/120.1.167","article-title":"Visual complications following irradiation for pituitary adenomas and craniopharyngiomas","volume":"120","author":"Harris","year":"1976","journal-title":"Radiology"},{"issue":"1\u20132","key":"2020071612075356500_B363","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0360-3016(77)90007-4","article-title":"Relationship of time dose factors to tumor control and complications in the treatment of Cushing's disease by irradiation","volume":"2","author":"Aristizabal","year":"1977","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"8","key":"2020071612075356500_B364","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/S0161-6420(85)33898-8","article-title":"Radiation optic neuropathy","volume":"92","author":"Kline","year":"1985","journal-title":"Ophthalmology"},{"issue":"6","key":"2020071612075356500_B365","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/j.1365-2265.1993.tb02137.x","article-title":"The long-term efficacy of conservative surgery and radiotherapy in the control of pituitary adenomas","volume":"38","author":"Brada","year":"1993","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"2020071612075356500_B366","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.radonc.2009.09.011","article-title":"Radiotherapy for pituitary adenomas: long-term efficacy and toxicity","volume":"93","author":"Erridge","year":"2009","journal-title":"Radiother Oncol"},{"issue":"5","key":"2020071612075356500_B367","first-page":"1022","article-title":"Radiosurgical management of benign cavernous sinus tumors: dose profiles and acute complications","volume":"48","author":"Chen","year":"2001","journal-title":"Neurosurgery"},{"issue":"5","key":"2020071612075356500_B368","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/S0360-3016(02)04380-8","article-title":"A study on the radiation tolerance of the optic nerves and chiasm after stereotactic radiosurgery","volume":"55","author":"Stafford","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"2020071612075356500_B369","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/1097-0215(20001220)90:6<343::AID-IJC6>3.0.CO;2-H","article-title":"Preservation of visual fields after peri-sellar gamma-knife radiosurgery","volume":"90","author":"Ove","year":"2000","journal-title":"Int J Cancer"},{"issue":"10","key":"2020071612075356500_B370","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1016\/S0161-6420(97)30084-0","article-title":"Radiation optic neuropathy after stereotactic radiosurgery","volume":"104","author":"Girkin","year":"1997","journal-title":"Ophthalmology"},{"issue":"2","key":"2020071612075356500_B371","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/0360-3016(93)90262-T","article-title":"Cavernous sinus cranial neuropathies: is there a dose-response relationship following radiosurgery?","volume":"27","author":"Mehta","year":"1993","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"2020071612075356500_B372","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1159\/000085544","article-title":"Gamma knife radiosurgery for tumors involving the cavernous sinus","volume":"83","author":"Liu","year":"2005","journal-title":"Stereotact Funct Neurosurg"},{"issue":"6","key":"2020071612075356500_B373","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1227\/01.NEU.0000124750.13721.94","article-title":"Gamma knife radiosurgery for benign cavernous sinus tumors: quantitative analysis of treatment outcomes","volume":"54","author":"Kuo","year":"2004","journal-title":"Neurosurgery"},{"issue":"5","key":"2020071612075356500_B374","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/j.1755-3768.1976.tb01291.x","article-title":"Atrophy of optic nerve fibres in compression of the chiasm. Degree and distribution of ophthalmoscopic changes","volume":"54","author":"Lundstr\u00f6m","year":"1976","journal-title":"Acta Ophthalmol (Copenh)"},{"issue":"1","key":"2020071612075356500_B375","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1159\/000047951","article-title":"Early palliation of oculomotor nerve palsy following gamma knife radiosurgery for pituitary adenoma","volume":"47","author":"Abe","year":"2002","journal-title":"Eur Neurol"},{"issue":"4","key":"2020071612075356500_B376","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1200\/JCO.2004.05.186","article-title":"Change in neurocognitive functioning after treatment with cranial radiation in childhood","volume":"22","author":"Spiegler","year":"2004","journal-title":"J Clin Oncol"},{"issue":"5","key":"2020071612075356500_B377","doi-asserted-by":"crossref","first-page":"707","DOI":"10.3171\/jns.1989.70.5.0707","article-title":"A prospective study of cognitive function in children receiving whole-brain radiotherapy and chemotherapy: 2-year results","volume":"70","author":"Packer","year":"1989","journal-title":"J Neurosurg"},{"issue":"2","key":"2020071612075356500_B378","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s11910-002-0021-6","article-title":"Radiation-induced neurocognitive decline: the risks and benefits of reducing the amount of whole-brain irradiation","volume":"2","author":"Packer","year":"2002","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"11","key":"2020071612075356500_B379","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s004150050271","article-title":"Neurological complications of radiotherapy and chemotherapy","volume":"245","author":"Keime-Guibert","year":"1998","journal-title":"J Neurol"},{"issue":"6","key":"2020071612075356500_B380","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1136\/jnnp.65.6.870","article-title":"Cognitive effects of pituitary tumours and their treatments: two case studies and an investigation of 90 patients","volume":"65","author":"Guinan","year":"1998","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"2020071612075356500_B381","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1046\/j.1365-2265.1998.00543.x","article-title":"Cognitive dysfunction in patients with pituitary tumour who have been treated with transfrontal or transsphenoidal surgery or medication","volume":"49","author":"Peace","year":"1998","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"2020071612075356500_B382","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S0360-3016(99)00159-5","article-title":"The incidence of cerebrovascular accidents in patients with pituitary adenoma","volume":"45","author":"Brada","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"2020071612075356500_B383","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1210\/jc.2004-1152","article-title":"Risk of second brain tumor after conservative surgery and radiotherapy for pituitary adenoma: update after an additional 10 years","volume":"90","author":"Minniti","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2020071612075356500_B384","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/1097-0142(194805)1:1<3::AID-CNCR2820010103>3.0.CO;2-7","article-title":"Sarcoma arising in irradiated bone; report of 11 cases","volume":"1","author":"Cahan","year":"1948","journal-title":"Cancer"},{"issue":"4","key":"2020071612075356500_B385","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.otc.2009.04.005","article-title":"Neoplastic transformation after radiosurgery or radiotherapy: risk and realities","volume":"42","author":"Niranjan","year":"2009","journal-title":"Otolaryngol Clin North Am"},{"issue":"5","key":"2020071612075356500_B386","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1365-2265.1991.tb03554.x","article-title":"Radiation oncogenesis in relation to the treatment of pituitary tumours","volume":"35","author":"Jones","year":"1991","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"2020071612075356500_B387","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/WNO.0b013e3181b4a1be","article-title":"Intracranial malignancies occurring more than 20 years after radiation therapy for pituitary adenoma","volume":"29","author":"Wu-Chen","year":"2009","journal-title":"J Neuroophthalmol"},{"issue":"4","key":"2020071612075356500_B388","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1215\/15228517-2007-027","article-title":"Glioblastoma multiforme after stereotactic radiotherapy for acoustic neuroma: case report and review of the literature","volume":"9","author":"Balasubramaniam","year":"2007","journal-title":"Neuro Oncol"},{"issue":"6","key":"2020071612075356500_B389","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1227\/01.NEU.0000064809.59806.E8","article-title":"Second tumors after radiosurgery: tip of the iceberg or a bump in the road?","volume":"52","author":"Loeffler","year":"2003","journal-title":"Neurosurgery"},{"issue":"5","key":"2020071612075356500_B390","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1586\/ern.13.37","article-title":"Radiation-associated secondary brain tumors after conventional radiotherapy and radiosurgery","volume":"13","author":"Ecemis","year":"2013","journal-title":"Expert Rev Neurother"},{"issue":"5","key":"2020071612075356500_B391","doi-asserted-by":"crossref","first-page":"629","DOI":"10.2169\/internalmedicine.31.629","article-title":"Meningioma developed 25 years after radiation therapy for Cushing's disease","volume":"31","author":"Tsukamoto","year":"1992","journal-title":"Intern Med"},{"issue":"4","key":"2020071612075356500_B392","doi-asserted-by":"crossref","first-page":"510","DOI":"10.3109\/02688697.2013.841850","article-title":"Radiation-induced opticochiasmatic glioblastoma multiforme following conventional radiotherapy for Cushing's disease","volume":"28","author":"Sarkar","year":"2014","journal-title":"Br J Neurosurg"},{"issue":"3","key":"2020071612075356500_B393","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/0360-3016(93)90080-F","article-title":"The radiobiology of radiosurgery","volume":"25","author":"Larson","year":"1993","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"2020071612075356500_B394","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1046\/j.0919-6544.2001.00426.x","article-title":"Histological changes in the pituitary gland and adenomas following radiotherapy","volume":"22","author":"Nishioka","year":"2002","journal-title":"Neuropathology"},{"issue":"6","key":"2020071612075356500_B395","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1210\/jcem-33-6-912","article-title":"Immediate effect of unilateral adrenalectomy followed by external pituitary irradiation on cortisol secretion rate in subjects suffering from pituitary dependent Cushing's syndrome","volume":"33","author":"Croughs","year":"1971","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2020071612075356500_B396","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1530\/acta.0.0860146","article-title":"Evaluation of a therapeutic regimen in Cushing's disease. The predictability of the result of unilateral adrenalectomy followed by external pituitary irradiation","volume":"86","author":"Lamberts","year":"1977","journal-title":"Acta Endocrinol (Copenh)"},{"issue":"3","key":"2020071612075356500_B397","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1365-2265.1978.tb02203.x","article-title":"Unilateral adrenalectomy and pituitary irradiation in the treatment of ACTH-dependent Cushing's disease in children and adolescents","volume":"9","author":"Landau","year":"1978","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"2020071612075356500_B398","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1046\/j.1365-2265.2000.00958.x","article-title":"Treatment of pituitary-dependent Cushing's syndrome: long-term results of unilateral adrenalectomy followed by external pituitary irradiation compared to transsphenoidal pituitary surgery","volume":"52","author":"Nagesser","year":"2000","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"10","key":"2020071612075356500_B399","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1002\/bjs.4738","article-title":"Laparoscopic adrenalectomy","volume":"91","author":"Assalia","year":"2004","journal-title":"Br J Surg"},{"issue":"8","key":"2020071612075356500_B400","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1590\/S0004-27302007000800021","article-title":"Role for laparoscopic adrenalectomy in patients with Cushing's syndrome","volume":"51","author":"Young","year":"2007","journal-title":"Arq Bras Endocrinol Metabol"},{"issue":"3","key":"2020071612075356500_B401","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.beem.2006.07.010","article-title":"Laparoscopic adrenalectomy","volume":"20","author":"Gumbs","year":"2006","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"2020071612075356500_B402","first-page":"3","article-title":"Adrenalectomy in Cushing's disease. A long-term follow-up","volume":"160","author":"Ernest","year":"1972","journal-title":"Acta Endocrinol Suppl (Copenh)"},{"issue":"5","key":"2020071612075356500_B403","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1097\/00000658-197705000-00004","article-title":"Surgical experience with Cushing's disease","volume":"185","author":"Scott","year":"1977","journal-title":"Ann Surg"},{"issue":"2","key":"2020071612075356500_B404","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1507\/endocrj1954.28.197","article-title":"Follow-up study on treatment in 27 patients with Cushing's disease: adrenalectomy, transsphenoidal adenomectomy and medical treatment","volume":"28","author":"Tomita","year":"1981","journal-title":"Endocrinol Jpn"},{"issue":"1","key":"2020071612075356500_B405","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/00005792-198101000-00002","article-title":"Cushing's disease\u201318 years' experience","volume":"60","author":"Urbanic","year":"1981","journal-title":"Medicine (Baltimore)"},{"issue":"206","key":"2020071612075356500_B406","first-page":"224","article-title":"Cushing's disease treated by total adrenalectomy: long-term observations of 43 patients","volume":"52","author":"Kelly","year":"1983","journal-title":"Q J Med"},{"key":"2020071612075356500_B407","first-page":"38","article-title":"Treatment of pituitary Cushing's disease: results of adrenal and pituitary surgery","volume":"251","author":"Pelkonen","year":"1983","journal-title":"Acta Endocrinol Suppl (Copenh)"},{"issue":"1","key":"2020071612075356500_B408","first-page":"16","article-title":"Survival and causes of death after adrenalectomy for Cushing's disease","volume":"97","author":"Welbourn","year":"1985","journal-title":"Surgery"},{"issue":"3","key":"2020071612075356500_B409","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1365-2265.1993.tb02371.x","article-title":"Bilateral adrenalectomy: low mortality and morbidity in Cushing's disease","volume":"39","author":"McCance","year":"1993","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"2020071612075356500_B410","first-page":"1088","article-title":"Long-term outcome of bilateral adrenalectomy in patients with Cushing's syndrome","volume":"116","author":"O'Riordain","year":"1994","journal-title":"Surgery"},{"issue":"1","key":"2020071612075356500_B411","first-page":"165","article-title":"The long-term outcome after adrenalectomy and prophylactic pituitary radiotherapy in adrenocorticotropin-dependent Cushing's syndrome","volume":"80","author":"Jenkins","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2020071612075356500_B412","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1007\/s004649900268","article-title":"Laparoscopic bilateral adrenalectomy following failed hypophysectomy","volume":"10","author":"Bax","year":"1996","journal-title":"Surg Endosc"},{"issue":"10","key":"2020071612075356500_B413","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1007\/s004649900220","article-title":"A comparison of open vs laparoscopic adrenalectomy","volume":"10","author":"MacGillivray","year":"1996","journal-title":"Surg Endosc"},{"issue":"6","key":"2020071612075356500_B414","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1097\/00000658-199612000-00008","article-title":"Laparoscopic unilateral and bilateral adrenalectomy for Cushing's syndrome. Transperitoneal and retroperitoneal approaches","volume":"224","author":"Fern\u00e1ndez-Cruz","year":"1996","journal-title":"Ann Surg"},{"issue":"7","key":"2020071612075356500_B415","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1002\/bjs.1800840731","article-title":"Bilateral laparoscopic adrenalectomy for Cushing's disease","volume":"84","author":"Chapuis","year":"1997","journal-title":"Br J Surg"},{"issue":"1","key":"2020071612075356500_B416","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0022-5347(01)65269-8","article-title":"Bilateral laparoscopic adrenalectomy for adrenocorticotropic dependent Cushing's syndrome","volume":"157","author":"Ferrer","year":"1997","journal-title":"J Urol"},{"issue":"2","key":"2020071612075356500_B417","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S0039-6060(98)70251-X","article-title":"Laparoscopic bilateral adrenalectomy for persistent Cushing's disease after transsphenoidal surgery","volume":"123","author":"Lanzi","year":"1998","journal-title":"Surgery"},{"issue":"6","key":"2020071612075356500_B418","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1067\/msy.2099.102423","article-title":"Laparoscopic versus open adrenalectomy in Cushing's syndrome and disease","volume":"126","author":"Acosta","year":"1999","journal-title":"Surgery"},{"issue":"1","key":"2020071612075356500_B419","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s002689910020","article-title":"Long-term results of total adrenalectomy for Cushing's disease","volume":"24","author":"Nagesser","year":"2000","journal-title":"World J Surg"},{"issue":"4","key":"2020071612075356500_B420","first-page":"1596","article-title":"Laparoscopic adrenalectomy for adrenocorticotropin-dependent Cushing's syndrome","volume":"86","author":"Vella","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2020071612075356500_B421","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1007\/BF03347498","article-title":"Bilateral adrenalectomy for Cushing's syndrome: a comparison between laparoscopy and open surgery","volume":"27","author":"Porpiglia","year":"2004","journal-title":"J Endocrinol Invest"},{"issue":"4","key":"2020071612075356500_B422","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.urology.2005.10.037","article-title":"Open versus laparoscopic simultaneous bilateral adrenalectomy","volume":"67","author":"Mikhail","year":"2006","journal-title":"Urology"},{"issue":"4","key":"2020071612075356500_B423","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1365-2265.2007.03082.x","article-title":"Bilateral laparoscopic adrenalectomy for corticotrophin-dependent Cushing's syndrome: a review of the Mayo Clinic experience","volume":"68","author":"Chow","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"2020071612075356500_B424","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.jamcollsurg.2009.02.054","article-title":"Bilateral adrenalectomy for refractory Cushing disease: a safe and definitive therapy","volume":"208","author":"Smith","year":"2009","journal-title":"J Am Coll Surg"},{"issue":"13","key":"2020071612075356500_B425","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.3760\/cma.j.issn.0366-6999.2010.13.008","article-title":"Role of adrenalectomy in recurrent Cushing's disease","volume":"123","author":"Ding","year":"2010","journal-title":"Chin Med J (Engl)"},{"issue":"2","key":"2020071612075356500_B426","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1089\/end.2011.0295","article-title":"Bilateral simultaneous laparoscopic adrenalectomy in Cushing's syndrome: safe, effective, and curative","volume":"26","author":"Tiyadatah","year":"2012","journal-title":"J Endourol"},{"issue":"3","key":"2020071612075356500_B427","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1080\/00015458.2013.11680912","article-title":"Comparison of laparoscopic and open adrenalectomy","volume":"113","author":"Bulus","year":"2013","journal-title":"Acta Chir Belg"},{"issue":"2","key":"2020071612075356500_B428","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1530\/EJE-14-0214","article-title":"Favorable long-term outcomes of bilateral adrenalectomy in Cushing's disease","volume":"171","author":"Osswald","year":"2014","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"2020071612075356500_B429","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s00268-013-2326-9","article-title":"Synchronous bilateral adrenalectomy for Cushing's syndrome: laparoscopic versus posterior retroperitoneoscopic versus robotic approach","volume":"38","author":"Raffaelli","year":"2014","journal-title":"World J Surg"},{"issue":"10","key":"2020071612075356500_B430","doi-asserted-by":"crossref","first-page":"3939","DOI":"10.1210\/jc.2013-1470","article-title":"Clinical review: outcome of bilateral adrenalectomy in Cushing's syndrome: a systematic review","volume":"98","author":"Ritzel","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2020071612075356500_B431","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1210\/jc.2006-1328","article-title":"Corticotroph tumor progression after adrenalectomy in Cushing's disease: a reappraisal of Nelson's syndrome","volume":"92","author":"Assi\u00e9","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2020071612075356500_B432","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s11102-005-1403-y","article-title":"The Nelson's syndrome\u2026 revisited","volume":"7","author":"Assi\u00e9","year":"2004","journal-title":"Pituitary"},{"issue":"8","key":"2020071612075356500_B433","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1590\/S0004-27302007000800026","article-title":"Nelson's syndrome","volume":"51","author":"Munir","year":"2007","journal-title":"Arq Bras Endocrinol Metabol"},{"issue":"3","key":"2020071612075356500_B434","doi-asserted-by":"crossref","first-page":"E13","DOI":"10.3171\/foc.2007.23.3.15","article-title":"Nelson syndrome: comprehensive review of pathophysiology, diagnosis, and management","volume":"23","author":"Banasiak","year":"2007","journal-title":"Neurosurg Focus"},{"issue":"4","key":"2020071612075356500_B435","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1530\/EJE-10-0466","article-title":"Nelson's syndrome","volume":"163","author":"Barber","year":"2010","journal-title":"Eur J Endocrinol"},{"issue":"12","key":"2020071612075356500_B436","doi-asserted-by":"crossref","first-page":"5465","DOI":"10.1210\/jc.2002-020299","article-title":"Neurosurgical treatment of Nelson's syndrome","volume":"87","author":"Kelly","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2020071612075356500_B437","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1055\/s-2006-921430","article-title":"Nelson's syndrome \u2013 46 years later: clinical experience with 37 patients","volume":"67","author":"Kasperlik-Za\u0142uska","year":"2006","journal-title":"Zentralbl Neurochir"},{"issue":"8","key":"2020071612075356500_B438","first-page":"1150","article-title":"Microsurgical treatment of Nelson's syndrome","volume":"115","author":"Xing","year":"2002","journal-title":"Chin Med J Engl"},{"issue":"1","key":"2020071612075356500_B439","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1046\/j.1365-2265.2001.01187.x","article-title":"Management of Nelson's syndrome: observations in fifteen patients","volume":"54","author":"Kemink","year":"2001","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"2020071612075356500_B440","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0889-8529(18)30271-8","article-title":"ACTH-producing pituitary tumors","volume":"20","author":"Grua","year":"1991","journal-title":"Endocrinol Metab Clin N Am"},{"issue":"1","key":"2020071612075356500_B441","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0303-8467(97)00124-8","article-title":"Beneficial gamma-knife radiosurgery in a patient with Nelson's syndrome","volume":"100","author":"Wolffenbuttel","year":"1998","journal-title":"Clin Neurol Neurosurg"},{"issue":"6","key":"2020071612075356500_B442","doi-asserted-by":"crossref","first-page":"731","DOI":"10.7326\/0003-4819-85-6-731","article-title":"Nelson's syndrome: frequency, prognosis, and effect of prior pituitary irradiation","volume":"85","author":"Moore","year":"1976","journal-title":"Ann Intern Med"},{"issue":"6","key":"2020071612075356500_B443","doi-asserted-by":"crossref","first-page":"988","DOI":"10.3171\/jns.2007.106.6.988","article-title":"Gamma knife surgery for adrenocorticotropic hormone-producing pituitary adenomas after bilateral adrenalectomy","volume":"106","author":"Mauermann","year":"2007","journal-title":"J Neurosurg"},{"issue":"2","key":"2020071612075356500_B444","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1530\/EJE-08-0687","article-title":"Gamma knife stereotactic radiosurgery of Nelson syndrome","volume":"160","author":"Vik-Mo","year":"2009","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"2020071612075356500_B445","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.3171\/foc.2003.14.5.13","article-title":"Stereotactic radiosurgery for hypersecreting pituitary tumors: part of a multimodality approach","volume":"14","author":"Jane","year":"2003","journal-title":"Neurosurg Focus"},{"issue":"3","key":"2020071612075356500_B446","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1007\/BF01655082","article-title":"The pituitary before and after adrenalectomy for Cushing's syndrome","volume":"8","author":"Manolas","year":"1984","journal-title":"World J Surg"},{"issue":"6","key":"2020071612075356500_B447","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.3171\/2013.7.JNS13389","article-title":"Effect of stereotactic radiosurgery before bilateral adrenalectomy for Cushing's disease on the incidence of Nelson's syndrome","volume":"119","author":"Mehta","year":"2013","journal-title":"J Neurosurg"},{"issue":"2","key":"2020071612075356500_B448","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.surg.2006.12.003","article-title":"Nelson's syndrome after bilateral adrenalectomy for Cushing's disease","volume":"141","author":"Gil-C\u00e1rdenas","year":"2007","journal-title":"Surgery"},{"issue":"11","key":"2020071612075356500_B449","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1007\/BF03343660","article-title":"Complete remission of Nelson's syndrome after 1-year treatment with cabergoline","volume":"22","author":"Pivonello","year":"1999","journal-title":"J Endocrinol Invest"},{"issue":"6","key":"2020071612075356500_B450","first-page":"300","article-title":"Nelson's syndrome: complete remission with cabergoline but not with bromocriptine or cyproheptadine treatment","volume":"62","author":"Casulari","year":"2004","journal-title":"Horm Res"},{"issue":"2","key":"2020071612075356500_B451","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s11102-006-9290-4","article-title":"Clinical and biochemical stabilization of Nelson's syndrome with long-term low-dose cabergoline treatment","volume":"9","author":"Shraga-Slutzky","year":"2006","journal-title":"Pituitary"},{"issue":"4","key":"2020071612075356500_B452","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1530\/eje.1.01876","article-title":"The multi-ligand somatostatin analogue SOM230 inhibits ACTH secretion by cultured human corticotroph adenomas via somatostatin receptor type 5","volume":"152","author":"Hofland","year":"2005","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"2020071612075356500_B453","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1210\/jc.2013-1497","article-title":"Sustained improvements in plasma ACTH and clinical status in a patient with Nelson's syndrome treated with pasireotide LAR, a multireceptor somatostatin analog","volume":"98","author":"Katznelson","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2020071612075356500_B454","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.1365-2265.2006.02501.x","article-title":"The PPAR-\u03b3 activator rosiglitazone fails to lower plasma ACTH levels in patients with Nelson's syndrome","volume":"64","author":"Mullan","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"2020071612075356500_B455","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1210\/jc.2006-2005","article-title":"Ineffectiveness of rosiglitazone therapy in Nelson's syndrome","volume":"92","author":"Munir","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612075356500_B456","first-page":"430","article-title":"No effect of the PPAR-\u03b3 agonist rosiglitazone on ACTH or cortisol secretion in Nelson's syndrome and Cushing's disease in vitro and in vivo","volume":"28","author":"Kreutzer","year":"2009","journal-title":"Clin Neuropathol"},{"issue":"1","key":"2020071612075356500_B457","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.humpath.2006.07.014","article-title":"Temozolomide therapy in a man with an aggressive prolactin-secreting pituitary neoplasm: morphological findings","volume":"38","author":"Kovacs","year":"2007","journal-title":"Hum Pathol"},{"issue":"4","key":"2020071612075356500_B458","doi-asserted-by":"crossref","first-page":"621","DOI":"10.3171\/jns.2006.105.4.621","article-title":"Long-term response of pituitary carcinoma to temozolomide. Report of two cases","volume":"105","author":"Fadul","year":"2006","journal-title":"J Neurosurg"},{"issue":"1","key":"2020071612075356500_B459","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1530\/EJE-08-0557","article-title":"Treatment of Nelson's syndrome with temozolomide","volume":"160","author":"Moyes","year":"2009","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"2020071612075356500_B460","doi-asserted-by":"crossref","first-page":"E10","DOI":"10.3171\/foc.2007.23.3.12","article-title":"Medical management of Cushing disease","volume":"23","author":"Gross","year":"2007","journal-title":"Neurosurg Focus"},{"issue":"4","key":"2020071612075356500_B461","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1517\/14728210903413522","article-title":"Drugs in the medical treatment of Cushing's syndrome","volume":"14","author":"Schteingart","year":"2009","journal-title":"Expert Opin Emerg Drugs"},{"key":"2020071612075356500_B462","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1159\/000318507","article-title":"Medical therapy of Cushing's disease: where are we now?","volume":"38","author":"Alexandraki","year":"2010","journal-title":"Front Horm Res"},{"issue":"4","key":"2020071612075356500_B463","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.nec.2012.06.012","article-title":"Medical management of persistent and recurrent Cushing disease","volume":"23","author":"Fleseriu","year":"2012","journal-title":"Neurosurg Clin N Am"},{"issue":"3","key":"2020071612075356500_B464","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1007\/s11102-012-0397-5","article-title":"Medical management of Cushing's disease: what is the future?","volume":"15","author":"Fleseriu","year":"2012","journal-title":"Pituitary"},{"issue":"6","key":"2020071612075356500_B465","doi-asserted-by":"crossref","first-page":"R205","DOI":"10.1530\/ERC-12-0191","article-title":"New developments in the medical treatment of Cushing's syndrome","volume":"19","author":"van der Pas","year":"2012","journal-title":"Endocr Relat Cancer"},{"issue":"2","key":"2020071612075356500_B466","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1210\/jc.2012-3126","article-title":"Medical treatment of Cushing's disease","volume":"98","author":"Feelders","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2020071612075356500_B467","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/MED.0b013e3283631809","article-title":"Update in the medical therapy of Cushing's disease","volume":"20","author":"Nieman","year":"2013","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"1","key":"2020071612075356500_B468","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/cen.12345","article-title":"Efficacy of medical treatment in Cushing's disease: a systematic review","volume":"80","author":"Gadelha","year":"2014","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"2020071612075356500_B469","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s11060-013-1269-1","article-title":"Medical management of Cushing's disease","volume":"117","author":"Tritos","year":"2014","journal-title":"J Neurooncol"},{"issue":"2","key":"2020071612075356500_B470","doi-asserted-by":"crossref","first-page":"R19","DOI":"10.1530\/JOE-14-0300","article-title":"Treatment of Cushing's disease: a mechanistic update","volume":"223","author":"Cuevas-Ramos","year":"2014","journal-title":"J Endocrinol"},{"key":"2020071612075356500_B471","doi-asserted-by":"crossref","first-page":"18","DOI":"10.12703\/P6-18","article-title":"Recent advances in the medical treatment of Cushing's disease","volume":"6","author":"Fleseriu","year":"2014","journal-title":"F1000Prime Rep"},{"issue":"7","key":"2020071612075356500_B472","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/BF00207474","article-title":"Steroid biosynthesis inhibitors in Cushing's syndrome","volume":"72","author":"Engelhardt","year":"1994","journal-title":"Clin Investig"},{"key":"2020071612075356500_B473","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0960-0760(94)90267-4","article-title":"Therapy of Cushing's syndrome with steroid biosynthesis inhibitors","volume":"49","author":"Engelhardt","year":"1994","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2020071612075356500_B474","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1159\/000314292","article-title":"Medical treatment of Cushing's syndrome: adrenal-blocking drugs and ketaconazole","volume":"92","author":"Feelders","year":"2010","journal-title":"Neuroendocrinology"},{"issue":"26","key":"2020071612075356500_B475","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.2174\/092986708786242921","article-title":"Steroid biosynthesis inhibitors in the therapy of hypercortisolism: theory and practice","volume":"15","author":"Igaz","year":"2008","journal-title":"Curr Med Chem"},{"issue":"3","key":"2020071612075356500_B476","doi-asserted-by":"crossref","first-page":"370","DOI":"10.7326\/0003-4819-97-3-370","article-title":"Ketoconazole blocks adrenal steroid synthesis","volume":"97","author":"Pont","year":"1982","journal-title":"Ann Intern Med"},{"issue":"5","key":"2020071612075356500_B477","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1172\/JCI110903","article-title":"Ketoconazole blocks adrenal steroidogenesis by inhibiting cytochrome P450-dependent enzymes","volume":"71","author":"Loose","year":"1983","journal-title":"J Clin Invest"},{"issue":"12","key":"2020071612075356500_B478","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1001\/archinte.1982.00340250097015","article-title":"Ketoconazole blocks testosterone synthesis","volume":"142","author":"Pont","year":"1982","journal-title":"Arch Intern Med"},{"issue":"4","key":"2020071612075356500_B479","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1210\/edrv-7-4-409","article-title":"Ketoconazole and other imidazole derivatives as inhibitors of steroidogenesis","volume":"7","author":"Feldman","year":"1986","journal-title":"Endocr Rev"},{"issue":"13","key":"2020071612075356500_B480","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1056\/NEJM198709243171307","article-title":"The use of ketoconazole as an inhibitor of steroid production","volume":"317","author":"Sonino","year":"1987","journal-title":"N Engl J Med"},{"issue":"2","key":"2020071612075356500_B481","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1210\/endo-122-2-618","article-title":"Ketoconazole inhibits corticotropic cell function in vitro","volume":"122","author":"Stalla","year":"1988","journal-title":"Endocrinology"},{"issue":"2","key":"2020071612075356500_B482","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1530\/acta.0.1210185","article-title":"In vitro effects of ketoconazole on corticotrope cell morphology and ACTH secretion of two pituitary adenomas removed from patients with Nelson's syndrome","volume":"121","author":"Jimenez Reina","year":"1989","journal-title":"Acta Endocrinol (Copenh)"},{"key":"2020071612075356500_B483","first-page":"58","article-title":"Effect of ketoconazole on CRH-induced ACTH and cortisol release in patients with Cushing's disease","volume":"16","author":"Berselli","year":"1987","journal-title":"Horm Metab Res Suppl"},{"issue":"4","key":"2020071612075356500_B484","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1365-2265.1987.tb01174.x","article-title":"Response of pituitary-adrenal axis to corticotrophin releasing hormone in patients with Cushing's disease before and after ketoconazole treatment","volume":"27","author":"Boscaro","year":"1987","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"2020071612075356500_B485","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1210\/jcem-61-4-718","article-title":"Prolonged treatment of Cushing's disease by ketoconazole","volume":"61","author":"Sonino","year":"1985","journal-title":"J Clin Endocrinol Metab"},{"issue":"8432","key":"2020071612075356500_B486","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S0140-6736(85)91482-5","article-title":"Ketoconazole therapy in Cushing's disease","volume":"1","author":"Angeli","year":"1985","journal-title":"Lancet"},{"issue":"6","key":"2020071612075356500_B487","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1210\/jcem-63-6-1365","article-title":"Use of ketoconazole in the treatment of Cushing's syndrome","volume":"63","author":"Loli","year":"1986","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2020071612075356500_B488","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/j.1365-2265.1987.tb01189.x","article-title":"Clinical experience with ketoconazole as a therapy for patients with Cushing's syndrome","volume":"27","author":"McCance","year":"1987","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"10","key":"2020071612075356500_B489","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1007\/BF03350926","article-title":"Ketoconazole treatment in Cushing's disease. Effect on the circadian profile of plasma ACTH and cortisol","volume":"11","author":"Terzolo","year":"1988","journal-title":"J Endocrinol Invest"},{"issue":"27","key":"2020071612075356500_B490","first-page":"1325","article-title":"Long-term treatment of Cushing's disease using ketoconazole. Possibility of therapeutic escape [in French]","volume":"18","author":"Diop","year":"1989","journal-title":"Presse Med"},{"issue":"6","key":"2020071612075356500_B491","first-page":"489","article-title":"Short term effects of ketoconazole in Cushing's syndrome [in French]","volume":"50","author":"Cerdas","year":"1989","journal-title":"Ann Endocrinol (Paris)"},{"issue":"4","key":"2020071612075356500_B492","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/BF01717326","article-title":"Different therapeutic efficacy of ketoconazole in patients with Cushing's syndrome","volume":"67","author":"Engelhardt","year":"1989","journal-title":"Klin Wochenschr"},{"issue":"1","key":"2020071612075356500_B493","first-page":"27","article-title":"Efficacy and long-term tolerance of ketoconazole in the treatment of Cushing's disease [in French]","volume":"51","author":"Tabarin","year":"1990","journal-title":"Ann Endocrinol (Paris)"},{"issue":"4","key":"2020071612075356500_B494","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1365-2265.1991.tb03547.x","article-title":"Ketoconazole treatment in Cushing's syndrome: experience in 34 patients","volume":"35","author":"Sonino","year":"1991","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"2020071612075356500_B495","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1365-2265.1991.tb01737.x","article-title":"Use of ketoconazole in the treatment of Cushing's disease and ectopic ACTH syndrome","volume":"34","author":"Tabarin","year":"1991","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"8","key":"2020071612075356500_B496","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/j.1440-1681.1991.tb01492.x","article-title":"Ketoconazole and plasma and urine steroid levels in Cushing's disease","volume":"18","author":"Mortimer","year":"1991","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"4","key":"2020071612075356500_B497","first-page":"358","article-title":"The effect of ketoconazole in pre-operative treatment in Cushing's syndrome: three cases report","volume":"19","author":"Li","year":"1996","journal-title":"Changgeng Yi Xue Za Zhi"},{"issue":"7","key":"2020071612075356500_B498","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1111\/j.1532-5415.1998.tb02723.x","article-title":"Corticotropin-dependent Cushing's syndrome in older people: presentation of five cases and therapeutical use of ketoconazole","volume":"46","author":"Berwaerts","year":"1998","journal-title":"J Am Geriatr Soc"},{"issue":"4","key":"2020071612075356500_B499","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1507\/endocrj.47.401","article-title":"Long-term effects of ketoconazole in the treatment of residual or recurrent Cushing's disease","volume":"47","author":"Chou","year":"2000","journal-title":"Endocr J"},{"issue":"3","key":"2020071612075356500_B500","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1023\/A:1015310806063","article-title":"The association of Cushing's disease and primary empty sella turcica","volume":"4","author":"Manavela","year":"2001","journal-title":"Pituitary"},{"issue":"1","key":"2020071612075356500_B501","first-page":"26","article-title":"Ketoconazole therapy: an efficacious alternative to achieve eucortisolism in patients with Cushing's syndrome","volume":"67","author":"Moncet","year":"2007","journal-title":"Medicina (B Aires)"},{"issue":"1","key":"2020071612075356500_B502","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1530\/EJE-07-0514","article-title":"Ketoconazole revisited: a preoperative or postoperative treatment in Cushing's disease","volume":"158","author":"Castinetti","year":"2008","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2020071612075356500_B503","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1365-2265.2009.03618.x","article-title":"Adrenocorticotrophic hormone (ACTH) responsiveness to ghrelin increases after 6 months of ketoconazole use in patients with Cushing's disease: comparison with GH-releasing peptide-6 (GHRP-6)","volume":"72","author":"Correa-Silva","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"2020071612075356500_B504","first-page":"271","article-title":"Effectiveness of chronic treatment with ketoconazole in a patient with diabetic Cushing's disease resistant to surgery","volume":"62","author":"Mert","year":"2011","journal-title":"Endokrynol Pol"},{"issue":"4","key":"2020071612075356500_B505","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1590\/S0004-27302011000400008","article-title":"Pseudotumor cerebri during Cushing's disease treatment with ketoconazole","volume":"55","author":"Costenaro","year":"2011","journal-title":"Arq Bras Endocrinol Metabol"},{"issue":"5","key":"2020071612075356500_B506","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/j.1365-2265.2012.04424.x","article-title":"A reappraisal of the medical therapy with steroidogenesis inhibitors in Cushing's syndrome","volume":"77","author":"Valassi","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"2020071612075356500_B507","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/cen.12286","article-title":"Increased long-term remission after adequate medical cortisol suppression therapy as presurgical treatment in Cushing's disease","volume":"80","author":"van den Bosch","year":"2014","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"2020071612075356500_B508","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1210\/jc.2013-3628","article-title":"Ketoconazole in Cushing's disease: is it worth a try?","volume":"99","author":"Castinetti","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2020071612075356500_B509","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1128\/AAC.31.12.1874","article-title":"Pharmacology and toxicity of high-dose ketoconazole","volume":"31","author":"Sugar","year":"1987","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"2020071612075356500_B510","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0016-5085(84)80021-9","article-title":"Hepatic injury associated with ketoconazole therapy. Analysis of 33 cases","volume":"86","author":"Lewis","year":"1984","journal-title":"Gastroenterology"},{"issue":"5","key":"2020071612075356500_B511","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1001\/archinte.1984.00350170237037","article-title":"Fatal hepatitis associated with ketoconazole therapy","volume":"144","author":"Duarte","year":"1984","journal-title":"Arch Intern Med"},{"key":"2020071612075356500_B512","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1136\/bmj.294.6569.419","article-title":"Hepatic reactions associated with ketoconazole in the United Kingdom","volume":"294","author":"Lake-Bakaar","year":"1987","journal-title":"Br Med J (Clin Res Ed)"},{"issue":"3","key":"2020071612075356500_B513","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1515\/JPEM.2001.14.3.335","article-title":"Fatal liver failure due to ketoconazole treatment of a girl with Cushing's syndrome","volume":"14","author":"Z\u00f6llner","year":"2001","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"8","key":"2020071612075356500_B514","doi-asserted-by":"crossref","first-page":"509","DOI":"10.2165\/11531320-000000000-00000","article-title":"Drug-drug interaction profiles of proton pump inhibitors","volume":"49","author":"Ogawa","year":"2010","journal-title":"Clin Pharmacokinet"},{"key":"2020071612075356500_B515","doi-asserted-by":"crossref","DOI":"10.1002\/0471140856.tx0413s20","article-title":"Human cytochrome P450: metabolism of testosterone by CYP3A4 and inhibition by ketoconazole","author":"Usmani","year":"2004","journal-title":"Curr Protoc Toxicol"},{"issue":"3","key":"2020071612075356500_B516","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3109\/09513599909167552","article-title":"Cushing's syndrome in pregnancy treated by ketoconazole: case report and review of the literature","volume":"13","author":"Berwaerts","year":"1999","journal-title":"Gynecol Endocrinol"},{"issue":"9","key":"2020071612075356500_B517","doi-asserted-by":"crossref","first-page":"675","DOI":"10.3109\/09513590.2010.521268","article-title":"Successful outcome of pregnancy in a patient with Cushing's disease under treatment with ketoconazole during the first trimester of gestation","volume":"27","author":"Boronat","year":"2011","journal-title":"Gynecol Endocrinol"},{"issue":"1","key":"2020071612075356500_B518","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejogrb.2012.12.015","article-title":"The medical management of Cushing's syndrome during pregnancy","volume":"168","author":"Lim","year":"2013","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"1","key":"2020071612075356500_B519","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1741-4520.2005.00053.x","article-title":"Population-based case-control study of oral ketoconazole treatment for birth outcomes","volume":"45","author":"Kazy","year":"2005","journal-title":"Congenit Anom (Kyoto)"},{"issue":"4","key":"2020071612075356500_B520","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/BF02157133","article-title":"New amphenone analogs as adrenocortical inhibitors","volume":"14","author":"Chart","year":"1958","journal-title":"Experientia"},{"issue":"8","key":"2020071612075356500_B521","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1210\/jcem-18-8-906","article-title":"Alterations of adrenal steroid patterns in man resulting from treatment with a chemical inhibitor of 11 \u03b2-hydroxylation","volume":"18","author":"Liddle","year":"1958","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2020071612075356500_B522","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1210\/jcem-42-4-687","article-title":"Dual sites of inhibition by metyrapone of human adrenal steroidogenesis: correlation of in vivo and in vitro studies","volume":"42","author":"Carballeira","year":"1976","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612075356500_B523","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/0022-4731(74)90051-X","article-title":"Modifiers of steroid-hormone metabolism: a review of their chemistry, biochemistry and clinical applications","volume":"5","author":"Gower","year":"1974","journal-title":"J Steroid Biochem"},{"issue":"6081","key":"2020071612075356500_B524","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1136\/bmj.2.6081.215","article-title":"Metyrapone in long-term management of Cushing's disease","volume":"2","author":"Jeffcoate","year":"1977","journal-title":"Br Med J"},{"issue":"730","key":"2020071612075356500_B525","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1136\/pgmj.62.730.727","article-title":"Successful control of Cushing's disease in the elderly with long term metyrapone","volume":"62","author":"Donckier","year":"1986","journal-title":"Postgrad Med J"},{"issue":"9","key":"2020071612075356500_B526","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1001\/jama.1986.03370090089027","article-title":"Primary therapy for Cushing's disease with metyrapone","volume":"255","author":"Dickstein","year":"1986","journal-title":"JAMA"},{"key":"2020071612075356500_B527","first-page":"782068","article-title":"Metyrapone for long-term medical management of Cushing's syndrome","volume":"2013","author":"Traina","year":"2013","journal-title":"Case Rep Endocrinol"},{"issue":"4","key":"2020071612075356500_B528","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1530\/acta.0.1090451","article-title":"Aminoglutethimide and metyrapone in the management of Cushing's syndrome","volume":"109","author":"Thor\u00e9n","year":"1985","journal-title":"Acta Endocrinol (Copenh)"},{"issue":"2","key":"2020071612075356500_B529","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1365-2265.1991.tb03517.x","article-title":"Short and long-term responses to metyrapone in the medical management of 91 patients with Cushing's syndrome","volume":"35","author":"Verhelst","year":"1991","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"2020071612075356500_B530","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0015-0282(99)00261-7","article-title":"Twin pregnancy in a patient with Cushing's disease","volume":"72","author":"Cabez\u00f3n","year":"1999","journal-title":"Fertil Steril"},{"issue":"5","key":"2020071612075356500_B531","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1210\/jc.2004-2361","article-title":"Cushing's syndrome during pregnancy: personal experience and review of the literature","volume":"90","author":"Lindsay","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2020071612075356500_B532","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1210\/jcem-27-4-481","article-title":"Effects of amino-glutethimide on adrenal function in man","volume":"27","author":"Fishman","year":"1967","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612075356500_B533","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1002\/j.1552-4604.1976.tb01504.x","article-title":"Aminoglutethimide in the treatment of Cushing's syndrome","volume":"16","author":"Misbin","year":"1976","journal-title":"J Clin Pharmacol"},{"issue":"1","key":"2020071612075356500_B534","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1365-2265.1977.tb02940.x","article-title":"Effect of aminoglutethimide on urinary cortisol and cortisol metabolites in adolescents with Cushing's syndrome","volume":"7","author":"Zachmann","year":"1977","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"2020071612075356500_B535","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1210\/jcem-47-5-1042","article-title":"Treatment of Cushing's syndrome with trilostane (WIN 24,540), an inhibitor of adrenal steroid biosynthesis","volume":"47","author":"Komanicky","year":"1978","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2020071612075356500_B536","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/j.1365-2265.1983.tb00590.x","article-title":"Experience with trilostane in the treatment of Cushing's syndrome","volume":"18","author":"Dewis","year":"1983","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"21","key":"2020071612075356500_B537","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1007\/BF01711723","article-title":"Adrenocortical suppression by a single induction dose of etomidate","volume":"62","author":"Allolio","year":"1984","journal-title":"Klin Wochenschr"},{"issue":"5","key":"2020071612075356500_B538","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.1365-2265.1984.tb00112.x","article-title":"The inhibition by etomidate of the 11 \u03b2-hydroxylation of cortisol","volume":"20","author":"Fry","year":"1984","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"2020071612075356500_B539","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1210\/jcem-58-5-947","article-title":"Inhibition by etomidate of steroidogenesis in isolated bovine adrenal cells","volume":"58","author":"Kenyon","year":"1984","journal-title":"J Clin Endocrinol Metab"},{"issue":"23","key":"2020071612075356500_B540","doi-asserted-by":"crossref","first-page":"3861","DOI":"10.1016\/0006-2952(84)90052-2","article-title":"Effects of etomidate on steroid biosynthesis in subcellular fractions of bovine adrenals","volume":"33","author":"Vanden Bossche","year":"1984","journal-title":"Biochem Pharmacol"},{"issue":"22","key":"2020071612075356500_B541","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1056\/NEJM198405313102202","article-title":"Inhibition of adrenal steroidogenesis by the anesthetic etomidate","volume":"310","author":"Wagner","year":"1984","journal-title":"N Engl J Med"},{"issue":"3","key":"2020071612075356500_B542","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1365-2265.1985.tb03241.x","article-title":"Effect of a single bolus of etomidate upon eight major corticosteroid hormones and plasma ACTH","volume":"22","author":"Allolio","year":"1985","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"2020071612075356500_B543","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0022-3565(25)22688-X","article-title":"Differential effects of the imidazole derivatives etomidate, ketoconazole and miconazole and of metyrapone on the secretion of cortisol and its precursors by human adrenocortical cells","volume":"240","author":"Lamberts","year":"1987","journal-title":"J Pharmacol Exp Ther"},{"issue":"8358","key":"2020071612075356500_B544","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0140-6736(83)91070-X","article-title":"Direct in vitro inhibition of adrenal steroidogenesis by etomidate","volume":"2","author":"Lambert","year":"1983","journal-title":"Lancet"},{"key":"2020071612075356500_B545","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1046\/j.1365-2362.2000.0300s3076.x","article-title":"New mechanisms of adrenostatic compounds in a human adrenocortical cancer cell line","volume":"30","author":"Fassnacht","year":"2000","journal-title":"Eur J Clin Invest"},{"issue":"7","key":"2020071612075356500_B546","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1055\/s-0030-1249629","article-title":"Etomidate unmasks intraadrenal regulation of steroidogenesis and proliferation in adrenal cortical cell lines","volume":"42","author":"Hahner","year":"2010","journal-title":"Horm Metab Res"},{"key":"2020071612075356500_B547","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1530\/acta.0.111S021","article-title":"Influence of low-dose etomidate on adrenal and gonadal steroid hormone secretion in normal men","volume":"113","author":"Engelhardt","year":"1986","journal-title":"Acta Endocrinologica"},{"issue":"3","key":"2020071612075356500_B548","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1097\/ALN.0b013e3181ff72b5","article-title":"Clinical and molecular pharmacology of etomidate","volume":"114","author":"Forman","year":"2011","journal-title":"Anesthesiology"},{"issue":"2","key":"2020071612075356500_B549","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1530\/EJE-12-0274","article-title":"Etomidate in the management of hypercortisolaemia in Cushing's syndrome: a review","volume":"167","author":"Preda","year":"2012","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"2020071612075356500_B550","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1530\/EJE-12-0698","article-title":"Etomidate in the emergency management of hypercortisolemia","volume":"167","author":"Soh","year":"2012","journal-title":"Eur J Endocrinol"},{"issue":"10","key":"2020071612075356500_B551","first-page":"3542","article-title":"Emergency and prolonged use of intravenous etomidate to control hypercortisolemia in a patient with Cushing's syndrome and peritonitis","volume":"83","author":"Drake","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2020071612075356500_B552","first-page":"140","article-title":"Efficient short-term control of hypercortisolaemia by low-dose etomidate in severe paediatric Cushing's disease","volume":"64","author":"Greening","year":"2005","journal-title":"Horm Res"},{"issue":"6","key":"2020071612075356500_B553","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1159\/000324419","article-title":"Use of intravenous etomidate to control acute psychosis induced by the hypercortisolaemia in severe paediatric Cushing's disease","volume":"75","author":"Chan","year":"2011","journal-title":"Horm Res Paediatr"},{"issue":"8","key":"2020071612075356500_B554","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/BF01735795","article-title":"Nonhypnotic low-dose etomidate for rapid correction of hypercortisolaemia in Cushing's syndrome","volume":"66","author":"Allolio","year":"1988","journal-title":"Klin Wochenschr"},{"issue":"5","key":"2020071612075356500_B555","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1210\/jcem-70-5-1426","article-title":"Infusion of low dose etomidate: correction of hypercortisolemia in patients with Cushing's syndrome and dose-response relationship in normal subjects","volume":"70","author":"Schulte","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2020071612075356500_B556","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1097\/PCC.0b013e318198b096","article-title":"A novel use of etomidate for intentional adrenal suppression to control severe hypercortisolemia in childhood","volume":"10","author":"Mettauer","year":"2009","journal-title":"Pediatr Crit Care Med"},{"issue":"5","key":"2020071612075356500_B557","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1213\/00000539-199411000-00020","article-title":"A comparison of two formulations for etomidate, 2-hydroxypropyl-\u03b2-cyclodextrin (HPCD) and propylene glycol","volume":"79","author":"Doenicke","year":"1994","journal-title":"Anesth Analg"},{"issue":"8","key":"2020071612075356500_B558","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/j.1365-2044.2005.04325.x","article-title":"Etomidate for emergency anaesthesia; mad, bad and dangerous to know?","volume":"60","author":"Morris","year":"2005","journal-title":"Anaesthesia"},{"issue":"8","key":"2020071612075356500_B559","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1093\/bja\/51.8.779","article-title":"Venous sequelae following etomidate","volume":"51","author":"Zacharias","year":"1979","journal-title":"Br J Anaesth"},{"issue":"4","key":"2020071612075356500_B560","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1093\/bja\/ael187","article-title":"Etomidate-Lipuro is associated with considerably less injection pain in children compared with propofol with added lidocaine","volume":"97","author":"Nyman","year":"2006","journal-title":"Br J Anaesth"},{"issue":"3","key":"2020071612075356500_B561","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1093\/bja\/79.3.386","article-title":"Haemolysis after etomidate: comparison of propylene glycol and lipid formulations","volume":"79","author":"Doenicke","year":"1997","journal-title":"Br J Anaesth"},{"issue":"1","key":"2020071612075356500_B562","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0272-6386(97)90577-1","article-title":"Propylene glycol-induced proximal renal tubular cell injury","volume":"30","author":"Yorgin","year":"1997","journal-title":"Am J Kidney Dis"},{"issue":"9","key":"2020071612075356500_B563","first-page":"4104","article-title":"Use of a parenteral propylene glycol-containing etomidate preparation for the long-term management of ectopic Cushing's syndrome","volume":"86","author":"Krakoff","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2020071612075356500_B564","first-page":"387","article-title":"Severe adrenal cortical atrophy (cytotoxic) and hepatic damage produced in dogs by feeding 2,2-bis(parachlorophenyl)-1,1-dichloroethane (DDD or TDE)","volume":"48","author":"Nelson","year":"1949","journal-title":"Arch Pathol (Chic)"},{"issue":"3","key":"2020071612075356500_B565","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1210\/endo-62-3-334","article-title":"Biological studies on an adrenocorticolytic agent and the isolation of the active components","volume":"62","author":"Cueto","year":"1958","journal-title":"Endocrinology"},{"issue":"1","key":"2020071612075356500_B566","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1210\/endo-65-1-80","article-title":"Effects of o,p' DDD on histology and 17-hydroxycorticosteroid output of the dog adrenal cortex","volume":"65","author":"Vilar","year":"1959","journal-title":"Endocrinology"},{"issue":"5","key":"2020071612075356500_B567","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S0039-128X(71)80157-5","article-title":"Studies on the site of action of o,p'-DDD in the dog adrenal cortex. 1. Inhibition of ACTH-mediated pregnenolone synthesis","volume":"17","author":"Hart","year":"1971","journal-title":"Steroids"},{"issue":"5","key":"2020071612075356500_B568","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0039-128X(71)80158-7","article-title":"Studies on the site of action of o,p'-DDD in the dog adrenal cortex. II. TPNH- and corticosteroid precursor-stimulation of o,p'-DDD inhibited steroidogenesis","volume":"17","author":"Hart","year":"1971","journal-title":"Steroids"},{"key":"2020071612075356500_B569","first-page":"127","article-title":"Ultrastructure of adrenal cortex of the dog during treatment with DDD","volume":"29","author":"Kaminsky","year":"1962","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"2020071612075356500_B570","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0041-008X(73)90185-3","article-title":"The effect of isomers of DDD on the ACTH-induced steroid output, histology and ultrastructure of the dog adrenal cortex","volume":"24","author":"Hart","year":"1973","journal-title":"Toxicol Appl Pharmacol"},{"issue":"6","key":"2020071612075356500_B571","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/0022-4731(73)90033-2","article-title":"Complexing of DDT and o,p'DDD with adrenal cytochrome P-450 hydroxylating systems","volume":"4","author":"Young","year":"1973","journal-title":"J Steroid Biochem"},{"issue":"5","key":"2020071612075356500_B572","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1507\/endocrj1954.32.615","article-title":"Effect of o,p'-DDD on cortisol metabolism in Cushing's syndrome of various etiology","volume":"32","author":"Koide","year":"1985","journal-title":"Endocrinol Jpn"},{"issue":"4","key":"2020071612075356500_B573","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1530\/EJE-10-0956","article-title":"Mitotane has a strong and a durable inducing effect on CYP3A4 activity","volume":"164","author":"van Erp","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"2020071612075356500_B574","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1210\/jcem-21-2-201","article-title":"Effect of o,p'DDD in a patient with Cushing's syndrome","volume":"21","author":"Southren","year":"1961","journal-title":"J Clin Endocrinol Metab"},{"issue":"15","key":"2020071612075356500_B575","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1056\/NEJM196910092811501","article-title":"Treatment of Cushing's disease. Correction of hypercortisolism by o,p'DDD without induction of aldosterone deficiency","volume":"281","author":"Temple","year":"1969","journal-title":"N Engl J Med"},{"issue":"5","key":"2020071612075356500_B576","first-page":"455","article-title":"Successful treatment of Cushing's disease with o,p'-DDD followed by pituitary irradiation in a 19-year-old male patient","volume":"15","author":"Dickerman","year":"1979","journal-title":"Isr J Med Sci"},{"issue":"9","key":"2020071612075356500_B577","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1056\/NEJM197903013000903","article-title":"Treatment of Cushing's disease by O,p'DDD. Survey of 62 cases","volume":"300","author":"Luton","year":"1979","journal-title":"N Engl J Med"},{"issue":"5","key":"2020071612075356500_B578","doi-asserted-by":"crossref","first-page":"613","DOI":"10.7326\/0003-4819-92-5-613","article-title":"Sustained remission of Cushing's disease with mitotane and pituitary irradiation","volume":"92","author":"Schteingart","year":"1980","journal-title":"Ann Intern Med"},{"issue":"16","key":"2020071612075356500_B579","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1056\/NEJM198110153051617","article-title":"Does mitotane reduce endogenous ACTH secretion?","volume":"305","author":"Takamatsu","year":"1981","journal-title":"N Engl J Med"},{"issue":"3","key":"2020071612075356500_B580","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/BF00315440","article-title":"Plasma level monitoring of mitotane (o,p'-DDD) and its metabolite (o,p'-DDE) during long-term treatment of Cushing's disease with low doses","volume":"41","author":"Benecke","year":"1991","journal-title":"Eur J Clin Pharmacol"},{"issue":"9182","key":"2020071612075356500_B581","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0140-6736(05)75699-3","article-title":"18 Years mitotane therapy for intractable Cushing's disease","volume":"354","author":"Kawai","year":"1999","journal-title":"Lancet"},{"issue":"4","key":"2020071612075356500_B582","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1530\/EJE-12-0358","article-title":"Efficiency and tolerance of mitotane in Cushing's disease in 76 patients from a single center","volume":"167","author":"Baudry","year":"2012","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2020071612075356500_B583","first-page":"49","article-title":"The protracted effect of o,p'-DDD in Cushing's disease and its impact on adrenal morphogenesis of young human embryo","volume":"50","author":"Leiba","year":"1989","journal-title":"Ann Endocrinol (Paris)"},{"issue":"6","key":"2020071612075356500_B584","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1210\/jcem-56-6-1094","article-title":"Effects of cyproheptadine, reserpine, and synthetic corticotropin-releasing factor on pituitary glands from patients with Cushing's disease","volume":"56","author":"Suda","year":"1983","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2020071612075356500_B585","first-page":"652","article-title":"Cortisol secretory patterns in Cushing's disease and response to cyproheptadine treatment","volume":"81","author":"van Waveren Hogervorst","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2020071612075356500_B586","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1210\/jcem-42-2-291","article-title":"Modification of adrenal function by the anti-serotonin agent cyproheptadine","volume":"42","author":"Plonk","year":"1976","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2020071612075356500_B587","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1210\/jcem-41-1-143","article-title":"Inhibition of ACTH response to oral and intravenous metyrapone by antiserotoninergic treatment in man","volume":"41","author":"Cavagnini","year":"1975","journal-title":"J Clin Endocrinol Metab"},{"issue":"18","key":"2020071612075356500_B588","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1056\/NEJM197510302931802","article-title":"Cyproheptadine-induced remission of Cushing's disease","volume":"293","author":"Krieger","year":"1975","journal-title":"N Engl J Med"},{"key":"2020071612075356500_B589","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1056\/NEJM197608122950715","article-title":"Letter: cyproheptadine for pituitary disorders","volume":"295","author":"Kriegert","year":"1976","journal-title":"N Engl J Med"},{"issue":"1","key":"2020071612075356500_B590","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1210\/edrv-4-1-22","article-title":"Physiopathology of Cushing's disease","volume":"4","author":"Krieger","year":"1983","journal-title":"Endocr Rev"},{"issue":"4","key":"2020071612075356500_B591","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1055\/s-0028-1095778","article-title":"Lack of effect of antiserotoninergic and\/or dopaminergic treatment in patients with pituitary-dependent Cushing's syndrome","volume":"11","author":"Ambrosi","year":"1979","journal-title":"Horm Metab Res"},{"issue":"20","key":"2020071612075356500_B592","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1056\/NEJM197611112952017","article-title":"More on cyproheptadine","volume":"295","author":"Tyrrell","year":"1976","journal-title":"N Engl J Med"},{"key":"2020071612075356500_B593","article-title":"Lack of effect of cyproheptadine in Cushing's disease and in Nelson's syndrome","volume":"312","author":"Copinschi","year":"1977","journal-title":"Acta Endocrinol (Copenh)"},{"key":"2020071612075356500_B594","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1530\/acta.0.1040160","article-title":"Sodium valproate and cyproheptadine may independently induce a remission in the same patient with Cushing's disease","volume":"104","author":"Koppeschaar","year":"1983","journal-title":"Acta Endocrinol (Copenh)"},{"issue":"3","key":"2020071612075356500_B595","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/BF03349961","article-title":"Cyproheptadine may act at the pituitary in Cushing's disease: evidence from CRF stimulation","volume":"12","author":"Tucci","year":"1989","journal-title":"J Endocrinol Invest"},{"issue":"2","key":"2020071612075356500_B596","first-page":"77","article-title":"Cyproheptadine in the control of Cushing's disease","volume":"149","author":"Hsu","year":"1981","journal-title":"Johns Hopkins Med J"},{"issue":"8022","key":"2020071612075356500_B597","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/S0140-6736(77)92402-3","article-title":"Cushing's disease: successful treatment with cyproheptadine","volume":"1","author":"Barnes","year":"1977","journal-title":"Lancet"},{"issue":"2","key":"2020071612075356500_B598","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/BF03347166","article-title":"Rebound elevation of cortisol following cyproheptadine withdrawal in Cushing's disease from a pituitary macroadenoma","volume":"10","author":"Ooi","year":"1987","journal-title":"J Endocrinol Invest"},{"key":"2020071612075356500_B599","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1056\/NEJM197608122950715","article-title":"Letter: cyproheptadine for pituitary disorders","volume":"295","author":"Middler","year":"1976","journal-title":"N Engl J Med"},{"key":"2020071612075356500_B600","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1056\/NEJM197703102961022","article-title":"More on cyproheptadine in Cushing's disease","volume":"296","author":"Ferrari","year":"1977","journal-title":"N Engl J Med"},{"issue":"6","key":"2020071612075356500_B601","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1136\/adc.54.6.466","article-title":"Cushing's disease presenting with growth failure: clinical remission during cyproheptadine therapy","volume":"54","author":"Grant","year":"1979","journal-title":"Arch Dis Child"},{"issue":"5","key":"2020071612075356500_B602","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1210\/jcem-51-5-1195","article-title":"Twelve-hour cycles of adrenocorticotropin and cortisol secretion in Cushing's disease","volume":"51","author":"Schteingart","year":"1980","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612075356500_B603","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1016\/S0140-6736(77)92585-5","article-title":"Treatment of Cushing's disease with cyproheptadine","volume":"1","author":"Pearce","year":"1977","journal-title":"Lancet"},{"issue":"8403","key":"2020071612075356500_B604","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/S0140-6736(84)90631-7","article-title":"Sodium valproate and metyrapone for pituitary-dependent Cushing's disease","volume":"2","author":"Glaser","year":"1984","journal-title":"Lancet"},{"issue":"6062","key":"2020071612075356500_B605","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1136\/bmj.1.6062.686-a","article-title":"Cushing's disease: failure of treatment with cyproheptadine","volume":"1","author":"Allgrove","year":"1977","journal-title":"Br Med J"},{"issue":"5","key":"2020071612075356500_B606","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/S0022-3476(77)81265-1","article-title":"Treatment of Cushing disease in childhood with cyproheptadine","volume":"90","author":"D'Ercole","year":"1977","journal-title":"J Pediatr"},{"issue":"8","key":"2020071612075356500_B607","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1001\/jama.1992.03480080043020","article-title":"Potential therapeutic effects of ritanserin in Cushing's disease","volume":"267","author":"Sonino","year":"1992","journal-title":"JAMA"},{"issue":"2","key":"2020071612075356500_B608","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1023\/A:1009986822146","article-title":"Effect of the serotonin antagonists ritanserin and ketanserin in Cushing's disease","volume":"3","author":"Sonino","year":"2000","journal-title":"Pituitary"},{"key":"2020071612075356500_B609","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1159\/000122564","article-title":"Effects of \u03b3-aminobutyric acid (GABA) and GABA antagonist drugs on ACTH release","volume":"16","author":"Makara","year":"1974","journal-title":"Neuroendocrinology"},{"key":"2020071612075356500_B610","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/j.1749-6632.1977.tb41881.x","article-title":"Neurotransmitter regulation of corticotropin-releasing factor in vitro","volume":"297","author":"Jones","year":"1977","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"2020071612075356500_B611","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0022-3476(83)80313-8","article-title":"Sodium valproate and corticotropin suppression in the child treated for seizures","volume":"102","author":"Kritzler","year":"1983","journal-title":"J Pediatr"},{"key":"2020071612075356500_B612","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/S0140-6736(82)92383-2","article-title":"Sodium valproate and heterogeneity of pituitary dependent Cushing's syndrome","volume":"1","author":"Koppeschaar","year":"1982","journal-title":"Lancet"},{"issue":"4","key":"2020071612075356500_B613","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1530\/acta.0.1070471","article-title":"Successful treatment with sodium valproate of a patient with Cushing's disease and gross enlargement of the pituitary","volume":"107","author":"Koppeschaar","year":"1984","journal-title":"Acta Endocrinol (Copenh)"},{"issue":"8395","key":"2020071612075356500_B614","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S0140-6736(84)91074-2","article-title":"Sodium valproate in Cushing's disease","volume":"2","author":"Cavagnini","year":"1984","journal-title":"Lancet"},{"issue":"4","key":"2020071612075356500_B615","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/BF03347595","article-title":"Effects of sodium-valproate administration on plasma ACTH levels in patients with ACTH hypersecretion","volume":"6","author":"Ambrosi","year":"1983","journal-title":"J Endocrinol Invest"},{"issue":"15","key":"2020071612075356500_B616","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1007\/BF01726927","article-title":"The effect of sodium valproate in Cushing's disease, Nelson's syndrome and Addison's disease","volume":"66","author":"Reincke","year":"1988","journal-title":"Klin Wochenschr"},{"issue":"2","key":"2020071612075356500_B617","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/BF03348396","article-title":"Lack of ACTH lowering effect of sodium valproate in patients with ACTH hypersecretion","volume":"7","author":"Loli","year":"1984","journal-title":"J Endocrinol Invest"},{"issue":"8264","key":"2020071612075356500_B618","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0140-6736(82)90422-6","article-title":"Valproate in Cushing's syndrome","volume":"1","author":"Allolio","year":"1982","journal-title":"Lancet"},{"key":"2020071612075356500_B619","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/j.1365-2265.1986.tb03621.x","article-title":"Response to neurotransmitter modulating drugs in patients with Cushing's disease","volume":"25","author":"Koppeschaar","year":"1986","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"7","key":"2020071612075356500_B620","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/BF03347989","article-title":"Failure of long-term therapy with sodium valproate in Cushing's disease","volume":"20","author":"Colao","year":"1997","journal-title":"J Endocrinol Invest"},{"issue":"11","key":"2020071612075356500_B621","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1007\/BF03349657","article-title":"Cyclical Cushing's disease and its successful control under sodium valproate","volume":"13","author":"Beckers","year":"1990","journal-title":"J Endocrinol Invest"},{"issue":"4","key":"2020071612075356500_B622","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1365-2265.1988.tb03668.x","article-title":"The combined use of sodium valproate and metyrapone in the treatment of Cushing's syndrome","volume":"28","author":"Nussey","year":"1988","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071612075356500_B623","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1530\/eje.1.02353","article-title":"Novel insights in dopamine receptor physiology","volume":"156","author":"Pivonello","year":"2007","journal-title":"Eur J Endocrinol"},{"issue":"7","key":"2020071612075356500_B624","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1016\/S0021-9258(17)38065-1","article-title":"Dopaminergic receptors in the anterior pituitary gland. Correlation of [3H]dihydroergocryptine binding with the dopaminergic control of prolactin release","volume":"253","author":"Caron","year":"1978","journal-title":"J Biol Chem"},{"issue":"6","key":"2020071612075356500_B625","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1210\/endo-107-6-1676","article-title":"The dopamine receptor in the intermediate lobe of the rat pituitary gland: pharmacological characterization","volume":"107","author":"Munemura","year":"1980","journal-title":"Endocrinology"},{"key":"2020071612075356500_B626","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1152\/physrev.1990.70.2.279","article-title":"Regulation of prolactin secretion at the level of the lactotroph","volume":"70","author":"Lamberts","year":"1990","journal-title":"Physiol Rev"},{"issue":"4","key":"2020071612075356500_B627","first-page":"1368","article-title":"Heterogeneous dopamine D2 receptor subtype messenger ribonucleic acid expression in clinically nonfunctioning pituitary adenomas","volume":"83","author":"Renner","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612075356500_B628","doi-asserted-by":"crossref","article-title":"Dopamine D2 receptor expression in the corticotroph cells of the human normal pituitary gland","author":"Pivonello","DOI":"10.1007\/s12020-016-1107-2"},{"issue":"3","key":"2020071612075356500_B629","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1385\/ENDO:14:3:329","article-title":"Dopamine D2 receptor gene expression in human adenohypophysial adenomas","volume":"14","author":"Stefaneanu","year":"2001","journal-title":"Endocrine"},{"key":"2020071612075356500_B630","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1530\/eje.1.02351","article-title":"Preclinical and clinical experiences with the role of dopamine receptors in the treatment of pituitary adenomas","volume":"156","author":"Ferone","year":"2007","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"2020071612075356500_B631","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1517\/13543784.11.6.787","article-title":"Dopamine receptor agonists for treating prolactinomas","volume":"11","author":"Colao","year":"2002","journal-title":"Expert Opin Investig Drugs"},{"issue":"4","key":"2020071612075356500_B632","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1210\/jc.2003-030859","article-title":"Dopamine receptor expression and function in clinically nonfunctioning pituitary tumors: comparison with the effectiveness of cabergoline treatment","volume":"89","author":"Pivonello","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2020071612075356500_B633","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1530\/eje.0.1430615","article-title":"Long-term treatment with the dopamine agonist quinagolide of patients with clinically non-functioning pituitary adenoma","volume":"143","author":"Nobels","year":"2000","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2020071612075356500_B634","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1365-2265.2005.02295.x","article-title":"Postoperative treatment of clinically nonfunctioning pituitary adenomas with dopamine agonists decreases tumour remnant growth","volume":"63","author":"Greenman","year":"2005","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"2020071612075356500_B635","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1210\/jc.2003-030837","article-title":"Dopamine receptor expression and function in corticotroph pituitary tumors","volume":"89","author":"Pivonello","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2020071612075356500_B636","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1210\/jcem-50-2-387","article-title":"[3H]Spiperone binding to human anterior pituitaries and pituitary adenomas secreting prolactin, growth hormone, and adrenocorticotropic hormone","volume":"50","author":"Cronin","year":"1980","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2020071612075356500_B637","first-page":"1931","article-title":"Dopamine D2 receptor imaging in pituitary adenomas using iodine-123-epidepride and SPECT","volume":"37","author":"Pirker","year":"1996","journal-title":"J Nucl Med"},{"issue":"5","key":"2020071612075356500_B638","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1365-2265.1981.tb00691.x","article-title":"Bromocriptine suppresses ACTH secretion from human pituitary tumour cells in culture by a dopaminergic mechanism","volume":"15","author":"Adams","year":"1981","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071612075356500_B639","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0014-5793(94)80387-0","article-title":"Induction of apoptosis in murine ACTH-secreting pituitary adenoma cells by bromocriptine","volume":"339","author":"Yin","year":"1994","journal-title":"FEBS Lett"},{"key":"2020071612075356500_B640","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1210\/jcem-51-2-307","article-title":"The mechanism of suppressive action of bromocriptine on ACTH secretion in patients with Cushing's and Nelson syndrome","volume":"51","author":"Lamberts","year":"1980","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612075356500_B641","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1159\/000317716","article-title":"Medical treatment in Cushing's syndrome: dopamine agonists and cabergoline","volume":"92","author":"Petrossians","year":"2010","journal-title":"Neuroendocrinology"},{"key":"2020071612075356500_B642","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/S0140-6736(76)90656-5","article-title":"Bromocriptine in Nelson's syndrome and Cushing's disease (Letter)","volume":"2","author":"Lamberts","year":"1976","journal-title":"Lancet"},{"key":"2020071612075356500_B643","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1365-2265.1977.tb01314.x","article-title":"The role of dopaminergic depletion in the pathogenesis of Cushing's disease and the possible consequences for medical therapy","volume":"7","author":"Lamberts","year":"1977","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"2020071612075356500_B644","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1055\/s-0029-1211361","article-title":"Effect of injectable bromocriptine in patients with Cushing's disease","volume":"103","author":"Invitti","year":"1995","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"2","key":"2020071612075356500_B645","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1210\/edrv-13-2-220","article-title":"Dopamine agonists and pituitary tumor shrinkage","volume":"13","author":"Bevan","year":"1992","journal-title":"Endocr Rev"},{"issue":"3","key":"2020071612075356500_B646","doi-asserted-by":"crossref","first-page":"207","DOI":"10.2169\/internalmedicine.35.207","article-title":"Cyclic Cushing's disease in long-term remission with a daily low dose of bromocriptine","volume":"35","author":"Adachi","year":"1996","journal-title":"Intern Med"},{"issue":"6","key":"2020071612075356500_B647","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/j.1365-2265.1986.tb01668.x","article-title":"A study of corticotroph adenomas in Cushing's disease: no evidence of intermediate lobe origin","volume":"24","author":"McNicol","year":"1986","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"2020071612075356500_B648","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1210\/jcem-68-2-495","article-title":"Bromocriptine-responsive Cushing's disease associated with anterior pituitary corticotroph hyperplasia or normal pituitary gland","volume":"68","author":"Croughs","year":"1989","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2020071612075356500_B649","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1530\/eje.0.1440051","article-title":"ACTH silent adenoma shrinking under cabergoline","volume":"144","author":"Petrossians","year":"2001","journal-title":"Eur J Endocrinol"},{"key":"2020071612075356500_B650","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s11102-011-0309-0","article-title":"Macrocorticotropinoma shrinkage and control of hypercortisolism under long-term cabergoline therapy: case report","volume":"15","author":"Manavela","year":"2012","journal-title":"Pituitary"},{"issue":"4","key":"2020071612075356500_B651","doi-asserted-by":"crossref","first-page":"493","DOI":"10.12816\/0003176","article-title":"Cushing's disease: sustained remission in five cases induced by medical therapy with the dopamine agonist cabergoline","volume":"12","author":"Elshafie","year":"2012","journal-title":"Sultan Qaboos Univ Med J"},{"key":"2020071612075356500_B652","doi-asserted-by":"crossref","DOI":"10.1136\/bcr.03.2012.6025","article-title":"Disappearance of pituitary macro adenoma with combination of ketoconazole and cabergoline treatment: an unusual case of Cushing's syndrome with interesting findings","volume":"2012","author":"Ahmed","year":"2012","journal-title":"BMJ Case Rep"},{"issue":"11","key":"2020071612075356500_B653","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1007\/BF03345309","article-title":"Effect of cabergoline treatment on Cushing's disease caused by aberrant adrenocorticotropin-secreting macroadenoma","volume":"27","author":"Miyoshi","year":"2004","journal-title":"J Endocrinol Invest"},{"issue":"2","key":"2020071612075356500_B654","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1007\/BF03343983","article-title":"Macroprolactinoma associated with Cushing's disease, successfully treated with cabergoline","volume":"25","author":"T'Sjoen","year":"2002","journal-title":"J Endocrinol Invest"},{"issue":"3","key":"2020071612075356500_B655","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1023\/A:1011499609096","article-title":"Double pituitary lesions in three patients with Cushing's disease","volume":"3","author":"Meij","year":"2000","journal-title":"Pituitary"},{"issue":"1","key":"2020071612075356500_B656","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1210\/jc.2008-1533","article-title":"The medical treatment of Cushing's disease: effectiveness of chronic treatment with the dopamine agonist cabergoline in patients unsuccessfully treated by surgery","volume":"94","author":"Pivonello","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612075356500_B657","article-title":"Impact of long-term cabergoline treatment on clinical, metabolic and hormonal features in patients with Cushing's syndrome","author":"Cozzolino"},{"issue":"5","key":"2020071612075356500_B658","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1530\/EJE-10-0382","article-title":"Cabergoline monotherapy in the long-term treatment of Cushing's disease","volume":"163","author":"Godbout","year":"2010","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"2020071612075356500_B659","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s11102-009-0209-8","article-title":"Effectiveness of cabergoline in monotherapy and combined with ketoconazole in the management of Cushing's disease","volume":"13","author":"Vilar","year":"2010","journal-title":"Pituitary"},{"issue":"2","key":"2020071612075356500_B660","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s11102-013-0475-3","article-title":"Combination therapy for Cushing's disease: effectiveness of two schedules of treatment: should we start with cabergoline or ketoconazole?","volume":"17","author":"Barbot","year":"2014","journal-title":"Pituitary"},{"issue":"6","key":"2020071612075356500_B661","doi-asserted-by":"crossref","first-page":"968","DOI":"10.4158\/EP10031.OR","article-title":"Efficacy of cabergoline in uncured (persistent or recurrent) Cushing disease after pituitary surgical treatment with or without radiotherapy","volume":"16","author":"Lila","year":"2010","journal-title":"Endocr Pract"},{"key":"2020071612075356500_B662","article-title":"Predictive value of acute cortisol response to cabergoline administration on the responsiveness of cortisol secretion to short and long term treatment with cabergoline","author":"Vitale"},{"key":"2020071612075356500_B663","article-title":"Long-term effectiveness of cabergoline treatment in Cushing's disease: comparison with D2 dopamine receptor expression","author":"Pivonello"},{"key":"2020071612075356500_B664","article-title":"Dopamine receptor expression and dopamine agonist effectiveness in corticotroph pituitary tumors; comparison with clinical, biochemical, radiological and pathological features of patients with Cushing's disease","author":"Pivonello"},{"issue":"9","key":"2020071612075356500_B665","doi-asserted-by":"crossref","first-page":"4493","DOI":"10.1210\/jc.2003-031746","article-title":"Dopamine receptor expression and function in human normal adrenal gland and adrenal tumors","volume":"89","author":"Pivonello","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2020071612075356500_B666","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1056\/NEJMoa062222","article-title":"Dopamine agonists and the risk of cardiac-valve regurgitation","volume":"356","author":"Schade","year":"2007","journal-title":"N Engl J Med"},{"issue":"1","key":"2020071612075356500_B667","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1056\/NEJMoa054830","article-title":"Valvular heart disease and the use of dopamine agonists for Parkinson's disease","volume":"356","author":"Zanettini","year":"2007","journal-title":"N Engl J Med"},{"key":"2020071612075356500_B668","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/AOG.0b013e31829e398a","article-title":"Cabergoline therapy for Cushing disease throughout pregnancy","volume":"122","author":"Woo","year":"2013","journal-title":"Obstet Gynecol"},{"issue":"3","key":"2020071612075356500_B669","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1006\/frne.1999.0183","article-title":"Somatostatin and its receptor family","volume":"20","author":"Patel","year":"1999","journal-title":"Front Neuroendocrinol"},{"issue":"2","key":"2020071612075356500_B670","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1210\/er.2010-0002","article-title":"Resistance to somatostatin analogs in acromegaly","volume":"32","author":"Colao","year":"2011","journal-title":"Endocr Rev"},{"issue":"6","key":"2020071612075356500_B671","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1007\/BF03351043","article-title":"Expression of somatostatin receptors on human pituitary adenomas in vivo and ex vivo","volume":"24","author":"Nielsen","year":"2001","journal-title":"J Endocrinol Invest"},{"issue":"11","key":"2020071612075356500_B672","doi-asserted-by":"crossref","first-page":"4482","DOI":"10.1210\/jc.2006-1245","article-title":"The effects of SOM230 on cell proliferation and adrenocorticotropin secretion in human corticotroph pituitary adenomas","volume":"91","author":"Batista","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2020071612075356500_B673","doi-asserted-by":"crossref","first-page":"E278","DOI":"10.1152\/ajpendo.00004.2005","article-title":"Distinct functional properties of native somatostatin receptor subtype 5 compared with subtype 2 in the regulation of ACTH release by corticotroph tumor cells","volume":"289","author":"van der Hoek","year":"2005","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2020071612075356500_B674","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0079-6123(10)82012-6","article-title":"Somatostatin analogues: treatment of pituitary and neuroendocrine tumors","volume":"182","author":"Colao","year":"2010","journal-title":"Prog Brain Res"},{"key":"2020071612075356500_B675","first-page":"82","article-title":"Role of somatostatin analogs in the management of non-functioning neuroendocrine tumors","volume":"26","author":"Pivonello","year":"2003","journal-title":"J Endocrinol Invest"},{"issue":"1","key":"2020071612075356500_B676","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1210\/endo-108-1-281","article-title":"Inhibition of adrenocorticotropin secretion by somatostatin in pituitary cells in culture","volume":"108","author":"Richardson","year":"1981","journal-title":"Endocrinology"},{"issue":"21","key":"2020071612075356500_B677","doi-asserted-by":"crossref","first-page":"6502","DOI":"10.1073\/pnas.79.21.6502","article-title":"Somatostatin inhibits multireceptor stimulation of cyclic AMP formation and corticotropin secretion in mouse pituitary tumor cells","volume":"79","author":"Heisler","year":"1982","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"2020071612075356500_B678","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1159\/000059430","article-title":"Somatostatin receptor subtypes 2 and 5 inhibit corticotropin-releasing hormone-stimulated adrenocorticotropin secretion from AtT-20 cells","volume":"75","author":"Strowski","year":"2002","journal-title":"Neuroendocrinology"},{"issue":"6","key":"2020071612075356500_B679","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1530\/acta.0.1200760","article-title":"The effect of the long-acting somatostatin analogue SMS 201\u2013995 on ACTH secretion in Nelson's syndrome and Cushing's disease","volume":"120","author":"Lamberts","year":"1989","journal-title":"Acta Endocrinol (Copenh)"},{"issue":"3","key":"2020071612075356500_B680","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1365-2265.1990.tb00867.x","article-title":"Treatment of Cushing's syndrome with the long-acting somatostatin analogue SMS 201\u2013995 (sandostatin)","volume":"32","author":"Invitti","year":"1990","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"2020071612075356500_B681","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/BF03349555","article-title":"Failure of somatostatin and octreotide to acutely affect the hypothalamic-pituitary-adrenal function in patients with corticotropin hypersecretion","volume":"13","author":"Ambrosi","year":"1990","journal-title":"J Endocrinol Invest"},{"issue":"2","key":"2020071612075356500_B682","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1530\/eje.0.1300125","article-title":"Octreotide exerts different effects in vivo and in vitro in Cushing's disease","volume":"130","author":"Stalla","year":"1994","journal-title":"Eur J Endocrinol"},{"key":"2020071612075356500_B683","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1159\/000080741","article-title":"Functional activity of the multiligand analog SOM230 at human recombinant somatostatin receptor subtypes supports its usefulness in neuroendocrine tumors","volume":"80","author":"Schmid","year":"2004","journal-title":"Neuroendocrinology"},{"key":"2020071612075356500_B684","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1159\/000314352","article-title":"Medical treatment of Cushing's disease: somatostatin analogues and pasireotide","volume":"92","author":"Pedroncelli","year":"2010","journal-title":"Neuroendocrinology"},{"issue":"8","key":"2020071612075356500_B685","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/nrd3788","article-title":"Pasireotide","volume":"11","author":"Feelders","year":"2012","journal-title":"Nat Rev Drug Discov"},{"issue":"7","key":"2020071612075356500_B686","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1517\/13543784.2010.495943","article-title":"Pasireotide for the treatment of Cushing's disease","volume":"19","author":"Arnaldi","year":"2010","journal-title":"Expert Opin Investig Drugs"},{"issue":"3","key":"2020071612075356500_B687","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1159\/000072798","article-title":"Role of glucocorticoids in the regulation of pituitary somatostatin receptor subtype (sst1-sst5) mRNA levels: evidence for direct and somatostatin-mediated effects","volume":"78","author":"Park","year":"2003","journal-title":"Neuroendocrinology"},{"issue":"4","key":"2020071612075356500_B688","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1210\/edrv-9-4-417","article-title":"The role of somatostatin in the regulation of anterior pituitary hormone secretion and the use of its analogs in the treatment of human pituitary tumors","volume":"9","author":"Lamberts","year":"1988","journal-title":"Endocr Rev"},{"issue":"5","key":"2020071612075356500_B689","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1055\/s-2007-1003660","article-title":"Effect of sandostatin on CRF-stimulated secretion of ACTH, \u03b2-lipotropin and \u03b2-endorphin","volume":"23","author":"Invitti","year":"1991","journal-title":"Horm Metab Res"},{"issue":"6","key":"2020071612075356500_B690","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/j.1365-2265.1989.tb00272.x","article-title":"The pituitary-adrenal response to CRF-41 is unaltered by intravenous somatostatin in normal subjects","volume":"30","author":"Stafford","year":"1989","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"2020071612075356500_B691","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/BF01468882","article-title":"Somatostatin: a potent inhibitor of ACTH-hypersecretion in adrenal insufficiency","volume":"54","author":"Fehm","year":"1976","journal-title":"Klin Wochenschr"},{"issue":"1","key":"2020071612075356500_B692","first-page":"68","article-title":"Effects of somatostatin and bromocryptine on the plasma ACTH level in bilaterally adrenalectomized patients with Cushing's disease","volume":"76","author":"Julesz","year":"1980","journal-title":"Endokrinologie"},{"issue":"843","key":"2020071612075356500_B693","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1136\/pgmj.72.843.53","article-title":"The effects of octreotide in a patient with Nelson's syndrome","volume":"72","author":"Kelestimur","year":"1996","journal-title":"Postgrad Med J"},{"issue":"2","key":"2020071612075356500_B694","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0014-5793(99)01236-3","article-title":"Regulation of mouse somatostatin receptor type 2 gene expression by glucocorticoids","volume":"459","author":"Kraus","year":"1999","journal-title":"FEBS Lett"},{"issue":"6","key":"2020071612075356500_B695","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1530\/eje.1.01914","article-title":"Regulation of ghrelin secretion by somatostatin analogs in rats","volume":"152","author":"Silva","year":"2005","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"2020071612075356500_B696","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1210\/me.2005-0283","article-title":"SOM230 inhibits insulin-like growth factor-I action in mammary gland development by pituitary independent mechanism: mediated through somatostatin subtype receptor 3?","volume":"20","author":"Ruan","year":"2006","journal-title":"Mol Endocrinol"},{"issue":"1","key":"2020071612075356500_B697","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1210\/jc.2008-1008","article-title":"Treatment of pituitary-dependent Cushing's disease with the multireceptor ligand somatostatin analog pasireotide (SOM230): a multicenter, phase II trial","volume":"94","author":"Boscaro","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2020071612075356500_B698","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1056\/NEJMoa1105743","article-title":"A 12-month phase 3 study of pasireotide in Cushing's disease","volume":"366","author":"Colao","year":"2012","journal-title":"N Engl J Med"},{"key":"2020071612075356500_B699","doi-asserted-by":"crossref","article-title":"Mechanism and management of hyperglycemia associated with pasireotide: results from studies in healthy volunteers","author":"Henry","DOI":"10.1210\/endo-meetings.2011.PART3.P30.P3-274"},{"issue":"2","key":"2020071612075356500_B700","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s11102-013-0483-3","article-title":"Managing hyperglycemia in patients with Cushing's disease treated with pasireotide: medical expert recommendations","volume":"17","author":"Colao","year":"2014","journal-title":"Pituitary"},{"issue":"1","key":"2020071612075356500_B701","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.diabet.2012.10.005","article-title":"Management of hyperglycaemia in Cushing's disease: experts' proposals on the use of pasireotide","volume":"39","author":"Reznik","year":"2013","journal-title":"Diabetes Metab"},{"issue":"3","key":"2020071612075356500_B702","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.diabres.2013.12.011","article-title":"Management of hyperglycemia associated with pasireotide (SOM230): healthy volunteer study","volume":"103","author":"Breitschaft","year":"2014","journal-title":"Diabetes Res Clin Pract"},{"issue":"3","key":"2020071612075356500_B703","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/cen.12431","article-title":"Pasireotide treatment significantly improves clinical signs and symptoms in patients with Cushing's disease: results from a Phase III study","volume":"81","author":"Pivonello","year":"2014","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071612075356500_B704","article-title":"The treatment with pasireotide in Cushing's disease: effects of long-term treatment on tumor mass in the experience of a single center [published online March 6, 2015]","author":"Simeoli","journal-title":"Endocrine"},{"issue":"4","key":"2020071612075356500_B705","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1007\/s11102-012-0427-3","article-title":"Pituitary-directed medical therapy with pasireotide for a corticotroph macroadenoma: pituitary volume reduction and literature review","volume":"15","author":"Shimon","year":"2012","journal-title":"Pituitary"},{"issue":"4","key":"2020071612075356500_B706","doi-asserted-by":"crossref","first-page":"e92","DOI":"10.4158\/EP12296.CR","article-title":"Effective long-term treatment of Cushing's disease with pasireotide: a case report","volume":"19","author":"Lu","year":"2013","journal-title":"Endocr Pract"},{"key":"2020071612075356500_B707","article-title":"Pasireotide can induce sustained decreases in urinary cortisol and provide clinical benefit in patients with Cushing's disease: results from an open-ended, open-label extension trial [published online December 24, 2014]","author":"Schopohl","journal-title":"Pituitary"},{"key":"2020071612075356500_B708","doi-asserted-by":"crossref","first-page":"99","DOI":"10.17925\/EE.2012.08.02.99","article-title":"Medical treatment of Cushing's disease with pasireotide","volume":"8","author":"Lacroix","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"2020071612075356500_B709","article-title":"Effectiveness of pasireotide treatment in patients with Cushing's disease: a national experience based on clinical practice","author":"Pivonello"},{"issue":"2","key":"2020071612075356500_B710","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1365-2265.2008.03486.x","article-title":"Significant response to pasireotide (SOM230) in the treatment of a patient with persistent, refractory Cushing's disease","volume":"71","author":"Cukier","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"2020071612075356500_B711","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s11102-013-0539-4","article-title":"Pasireotide monotherapy in Cushing's disease: a single-centre experience with 5-year extension of phase III Trial","volume":"17","author":"MacKenzie Feder","year":"2014","journal-title":"Pituitary"},{"key":"2020071612075356500_B712","first-page":"735489","article-title":"Monitoring patient improvement parameters following pasireotide treatment in Cushing's disease","volume":"2013","author":"Yedinak","year":"2013","journal-title":"Case Rep Endocrinol"},{"issue":"3","key":"2020071612075356500_B713","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s11102-014-0582-9","article-title":"Up-to 5-year efficacy of pasireotide in a patient with Cushing's disease and pre-existing diabetes: literature review and clinical practice considerations","volume":"18","author":"Trementino","year":"2015","journal-title":"Pituitary"},{"issue":"6294","key":"2020071612075356500_B714","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/347645a0","article-title":"Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators","volume":"347","author":"Issemann","year":"1990","journal-title":"Nature"},{"issue":"6","key":"2020071612075356500_B715","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.cell.2005.11.026","article-title":"The many faces of PPAR\u03b3","volume":"123","author":"Lehrke","year":"2005","journal-title":"Cell"},{"issue":"3","key":"2020071612075356500_B716","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1023\/B:PITU.0000011176.05771.46","article-title":"Novel pituitary ligands: peroxisome proliferator activating receptor-\u03b3","volume":"6","author":"Heaney","year":"2003","journal-title":"Pituitary"},{"issue":"4","key":"2020071612075356500_B717","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s11102-005-1430-8","article-title":"PPAR-\u03b3 in Cushing's disease","volume":"7","author":"Heaney","year":"2004","journal-title":"Pituitary"},{"key":"2020071612075356500_B718","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1159\/000314312","article-title":"Role of the PPAR-\u03b3 system in normal and tumoral pituitary corticotropic cells and adrenal cells","volume":"92","author":"Mannelli","year":"2010","journal-title":"Neuroendocrinology"},{"issue":"11","key":"2020071612075356500_B719","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1038\/nm784","article-title":"Functional PPAR-\u03b3 receptor is a novel therapeutic target for ACTH-secreting pituitary adenomas","volume":"8","author":"Heaney","year":"2002","journal-title":"Nat Med"},{"issue":"3","key":"2020071612075356500_B720","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1089\/15209150050194297","article-title":"Thiazolidinediones: a comparative review of approved uses","volume":"2","author":"Sood","year":"2000","journal-title":"Diabetes Technol Ther"},{"issue":"3","key":"2020071612075356500_B721","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/pds.3736","article-title":"Was there really any evidence that rosiglitazone increased the risk of myocardial infarction or death from cardiovascular causes?","volume":"24","author":"Stone","year":"2015","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"9","key":"2020071612075356500_B722","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1172\/JCI200316575","article-title":"PPAR-\u03b3 receptor ligands: novel therapy for pituitary adenomas","volume":"111","author":"Heaney","year":"2003","journal-title":"J Clin Invest"},{"issue":"5","key":"2020071612075356500_B723","doi-asserted-by":"crossref","first-page":"RC8","DOI":"10.1007\/BF03345281","article-title":"Baseline and CRH-stimulated ACTH and cortisol levels after administration of the peroxisome proliferator-activated receptor-\u03b3 ligand, rosiglitazone, in Cushing's disease","volume":"27","author":"Cannav\u00f2","year":"2004","journal-title":"J Endocrinol Invest"},{"key":"2020071612075356500_B724","article-title":"Significant improvement of recurrent pituitary-dependent Cushing's syndrome after administration of a PPAR-\u03b3 agonist","author":"Alevizaki"},{"key":"2020071612075356500_B725","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1365-2265.2005.02193.x","article-title":"Pre-operative medical therapy with rosiglitazone in two patients with newly diagnosed pituitary-dependent Cushing's syndrome","volume":"62","author":"Hull","year":"2005","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071612075356500_B726","article-title":"Functional PPAR-\u03b3 receptor is a novel target for ACTH-secreting pituitary adenomas (Cushing's disease)","author":"Heaney"},{"issue":"2","key":"2020071612075356500_B727","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1530\/eje.0.1510173","article-title":"Effects of chronic administration of PPAR-\u03b3 ligand rosiglitazone in Cushing's disease","volume":"151","author":"Ambrosi","year":"2004","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"2020071612075356500_B728","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1365-2265.2006.02452.x","article-title":"Effect of protracted treatment with rosiglitazone, a PPAR\u03b3 agonist, in patients with Cushing's disease","volume":"64","author":"Pecori Giraldi","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"2020071612075356500_B729","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1055\/s-2007-970162","article-title":"Long-term treatment of central Cushing's syndrome with rosiglitazone","volume":"115","author":"Morcos","year":"2007","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"3","key":"2020071612075356500_B730","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1210\/jc.2004-1746","article-title":"Effect of pioglitazone on adrenocorticotropic hormone and cortisol secretion in Cushing's disease","volume":"90","author":"Suri","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612075356500_B731","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1007\/BF03347209","article-title":"Pioglitazone treatment in Cushing's disease","volume":"28","author":"Barbaro","year":"2005","journal-title":"J Endocrinol Invest"},{"key":"2020071612075356500_B732","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1172\/JCI11098","article-title":"Retinoic acid prevents experimental Cushing syndrome","volume":"108","author":"P\u00e1ez-Pereda","year":"2001","journal-title":"J Clin Invest"},{"key":"2020071612075356500_B733","doi-asserted-by":"crossref","first-page":"4438","DOI":"10.1210\/en.2006-0414","article-title":"Retinoic acid as a novel medical therapy for Cushing's disease in dogs","volume":"147","author":"Castillo","year":"2006","journal-title":"Endocrinology"},{"key":"2020071612075356500_B734","doi-asserted-by":"crossref","first-page":"5946","DOI":"10.1128\/MCB.17.10.5946","article-title":"Novel dimeric Nur77 signaling mechanism in endocrine and lymphoid cells","volume":"17","author":"Philips","year":"1997","journal-title":"Mol Cell Biol"},{"issue":"10","key":"2020071612075356500_B735","doi-asserted-by":"crossref","first-page":"4666","DOI":"10.1128\/MCB.12.10.4666","article-title":"COUP orphan receptors are negative regulators of retinoic acid response pathways","volume":"12","author":"Tran","year":"1992","journal-title":"Mol Cell Biol"},{"issue":"6","key":"2020071612075356500_B736","first-page":"745","article-title":"Corticotropin-releasing hormone stimulates proopiomelanocortin transcription by cFos-dependent and -independent pathways: characterization of an AP1 site in exon 1","volume":"9","author":"Boutillier","year":"1995","journal-title":"Mol Endocrinol"},{"issue":"4","key":"2020071612075356500_B737","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1073\/pnas.89.4.1448","article-title":"Retinoid X receptor-COUP-TF interactions modulate retinoic acid signaling","volume":"89","author":"Kliewer","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"2020071612075356500_B738","doi-asserted-by":"crossref","first-page":"4152","DOI":"10.1016\/S0021-9258(18)53592-4","article-title":"Multiple mechanisms of chicken ovalbumin upstream promoter transcription factor-dependent repression of transactivation by the vitamin D, thyroid hormone, and retinoic acid receptors","volume":"268","author":"Cooney","year":"1993","journal-title":"J Biol Chem"},{"issue":"2","key":"2020071612075356500_B739","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/1523-1747.ep12371770","article-title":"In vivo prevention of corticosteroid-induced skin atrophy by tretinoin in the hairless mouse is accompanied by modulation of collagen, glycosaminoglycans, and fibronectin","volume":"102","author":"Schwartz","year":"1994","journal-title":"J Invest Dermatol"},{"issue":"10","key":"2020071612075356500_B740","doi-asserted-by":"crossref","first-page":"3577","DOI":"10.1210\/jc.2012-2328","article-title":"Potential role for retinoic acid in patients with Cushing's disease","volume":"97","author":"Pecori Giraldi","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612075356500_B741","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1159\/000314224","article-title":"Medical treatment of Cushing's syndrome: glucocorticoid receptor antagonists and mifepristone","volume":"92","author":"Castinetti","year":"2010","journal-title":"Neuroendocrinology"},{"issue":"4","key":"2020071612075356500_B742","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/MED.0b013e32835430bf","article-title":"The use of the glucocorticoid receptor antagonist mifepristone in Cushing's syndrome","volume":"19","author":"Castinetti","year":"2012","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"5","key":"2020071612075356500_B743","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1530\/EJE-07-0458","article-title":"Mifepristone (RU 486) in Cushing's syndrome","volume":"157","author":"Johanssen","year":"2007","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2020071612075356500_B744","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s12020-012-9846-1","article-title":"Mifepristone: is there a place in the treatment of Cushing's disease?","volume":"44","author":"Carmichael","year":"2013","journal-title":"Endocrine"},{"issue":"2","key":"2020071612075356500_B745","doi-asserted-by":"crossref","first-page":"313","DOI":"10.4158\/EP12149.RA","article-title":"A new therapeutic approach in the medical treatment of Cushing's syndrome: glucocorticoid receptor blockade with mifepristone","volume":"19","author":"Fleseriu","year":"2013","journal-title":"Endocr Pract"},{"issue":"3","key":"2020071612075356500_B746","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/phar.1202","article-title":"Mifepristone for management of Cushing's syndrome","volume":"33","author":"Morgan","year":"2013","journal-title":"Pharmacotherapy"},{"issue":"1","key":"2020071612075356500_B747","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0014-4827(83)90282-3","article-title":"Inhibition of glucocorticosteroid action in cultured L-929 mouse fibroblasts by RU 486, a new anti-glucocorticosteroid of high affinity for the glucocorticosteroid receptor","volume":"147","author":"Jung-Testas","year":"1983","journal-title":"Exp Cell Res"},{"issue":"1","key":"2020071612075356500_B748","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1210\/jcem-59-1-25","article-title":"The new steroid analog RU 486 inhibits glucocorticoid action in man","volume":"59","author":"Bertagna","year":"1984","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2020071612075356500_B749","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/j.1460-2075.1984.tb01879.x","article-title":"DNA binding properties of glucocorticosteroid receptors bound to the steroid antagonist RU-486","volume":"3","author":"Bourgeois","year":"1984","journal-title":"EMBO J"},{"issue":"2","key":"2020071612075356500_B750","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0022-4731(87)90083-5","article-title":"Plasma concentrations and receptor binding of RU 486 and its metabolites in humans","volume":"26","author":"Heikinheimo","year":"1987","journal-title":"J Steroid Biochem"},{"key":"2020071612075356500_B751","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1146\/annurev.med.48.1.129","article-title":"RU486 (mifepristone): mechanisms of action and clinical uses","volume":"48","author":"Cadepond","year":"1997","journal-title":"Annu Rev Med"},{"issue":"6","key":"2020071612075356500_B752","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0010-7824(03)00171-9","article-title":"Pharmacological properties of mifepristone: toxicology and safety in animal and human studies","volume":"68","author":"Sitruk-Ware","year":"2003","journal-title":"Contraception"},{"issue":"2","key":"2020071612075356500_B753","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1055\/s-2004-835369","article-title":"Cortisol, 11\u03b2-hydroxysteroid dehydrogenases, and hypertension","volume":"4","author":"van Uum","year":"2004","journal-title":"Semin Vasc Med"},{"issue":"3","key":"2020071612075356500_B754","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1210\/jcem-61-3-536","article-title":"Successful treatment of Cushing's syndrome with the glucocorticoid antagonist RU 486","volume":"61","author":"Nieman","year":"1985","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2020071612075356500_B755","first-page":"3568","article-title":"Successful long-term treatment of refractory Cushing's disease with high-dose mifepristone (RU 486)","volume":"86","author":"Chu","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2020071612075356500_B756","doi-asserted-by":"crossref","first-page":"e114","DOI":"10.4158\/EP11391.CR","article-title":"Successful long-term treatment of Cushing disease with mifepristone (RU486)","volume":"18","author":"Basina","year":"2012","journal-title":"Endocr Pract"},{"issue":"6","key":"2020071612075356500_B757","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1530\/EJE-09-0098","article-title":"Merits and pitfalls of mifepristone in Cushing's syndrome","volume":"160","author":"Castinetti","year":"2009","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"2020071612075356500_B758","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1210\/jc.2011-3350","article-title":"Mifepristone, a glucocorticoid receptor antagonist, produces clinical and metabolic benefits in patients with Cushing's syndrome","volume":"97","author":"Fleseriu","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2020071612075356500_B759","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1111\/cen.12332","article-title":"Global clinical response in Cushing's syndrome patients treated with mifepristone","volume":"80","author":"Katznelson","year":"2014","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"9","key":"2020071612075356500_B760","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.2337\/dc13-0246","article-title":"Improvement in insulin sensitivity during mifepristone treatment of Cushing syndrome: early and late effects","volume":"36","author":"Wallia","year":"2013","journal-title":"Diabetes Care"},{"issue":"5","key":"2020071612075356500_B761","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/modpathol.2008.19","article-title":"The spectrum of endometrial pathology induced by progesterone receptor modulators","volume":"21","author":"Mutter","year":"2008","journal-title":"Mod Pathol"},{"issue":"10","key":"2020071612075356500_B762","doi-asserted-by":"crossref","first-page":"3718","DOI":"10.1210\/jc.2014-1843","article-title":"Changes in plasma ACTH levels and corticotroph tumor size in patients with Cushing's disease during long-term treatment with the glucocorticoid receptor antagonist mifepristone","volume":"99","author":"Fleseriu","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"8552","key":"2020071612075356500_B763","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0140-6736(87)90796-3","article-title":"RU 486 administration in a child with Cushing's syndrome","volume":"2","author":"Beaufr\u00e8re","year":"1987","journal-title":"Lancet"},{"issue":"1","key":"2020071612075356500_B764","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1210\/jcem-70-1-230","article-title":"Transient inhibition of RU 486 antiglucocorticoid action by dexamethasone","volume":"70","author":"Raux-Demay","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2020071612075356500_B765","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1530\/acta.0.0820330","article-title":"Drug controlled of Cushing's syndrome. Combined aminoglutethimide and metyrapone therapy","volume":"82","author":"Child","year":"1976","journal-title":"Acta Endocrinol (Copenh)"},{"issue":"9","key":"2020071612075356500_B766","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1210\/jc.2011-0536","article-title":"Mitotane, metyrapone, and ketoconazole combination therapy as an alternative to rescue adrenalectomy for severe ACTH-dependent Cushing's syndrome","volume":"96","author":"Kamenick\u00fd","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612075356500_B767","article-title":"Effectiveness and safety of combined therapy with low dose ketoconazole and cabergoline in patients with Cushing's disease partially responsive to monotherapy with cabergoline","author":"Pivonello"},{"issue":"19","key":"2020071612075356500_B768","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1056\/NEJMc1000094","article-title":"Pasireotide alone or with cabergoline and ketoconazole in Cushing's disease","volume":"362","author":"Feelders","year":"2010","journal-title":"N Engl J Med"},{"key":"2020071612075356500_B769","doi-asserted-by":"crossref","DOI":"10.1016\/S0735-1097(10)60584-0","article-title":"Hormonal and electrolyte responses to the aldosterone synthase inhibitor LCI699 in sodium depleted healthy subjects","volume":"55","author":"Menard","year":"2010","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"2020071612075356500_B770","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1161\/HYPERTENSIONAHA.110.157271","article-title":"Aldosterone synthase inhibition with LCI699: a proof-of-concept study in patients with primary aldosteronism","volume":"56","author":"Amar","year":"2010","journal-title":"Hypertension"},{"issue":"18","key":"2020071612075356500_B771","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1161\/CIRCULATIONAHA.111.029892","article-title":"Effects of a novel aldosterone synthase inhibitor for treatment of primary hypertension: results of a randomized, double-blind, placebo- and active-controlled phase 2 trial","volume":"124","author":"Calhoun","year":"2011","journal-title":"Circulation"},{"issue":"4","key":"2020071612075356500_B772","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1210\/jc.2013-2117","article-title":"LCI699, a potent 11\u03b2-hydroxylase inhibitor, normalizes urinary cortisol in patients with Cushing's disease: results from a multicenter, proof-of-concept study","volume":"99","author":"Bertagna","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612075356500_B773","article-title":"Patients with Cushing's disease achieve normal urinary cortisol with LCI699, a potent 11\u03b2-hydroxylase inhibitor: preliminary results from a multicenter, proof-of-concept study","author":"Pivonello"},{"key":"2020071612075356500_B774","article-title":"LCI699, a potent 11\u03b2-hydroxylase Inhibitor, normalizes urinary free cortisol level in patients with Cushing's disease: 22-week, multicenter, open-label study","author":"Pivonello"},{"key":"2020071612075356500_B775","article-title":"Efficacy and safety of LCI699, a potent 11\u03b2-hydroxylase inhibitor, in patients with Cushing's disease: a 22 week, multicenter, open-label study","author":"Pivonello"},{"issue":"2","key":"2020071612075356500_B776","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1677\/joe.1.05616","article-title":"Expression of epidermal growth factor receptor in neoplastic pituitary cells: evidence for a role in corticotropinoma cells","volume":"183","author":"Theodoropoulou","year":"2004","journal-title":"J Endocrinol"},{"issue":"12","key":"2020071612075356500_B777","doi-asserted-by":"crossref","first-page":"4712","DOI":"10.1172\/JCI60417","article-title":"EGFR as a therapeutic target for human, canine, and mouse ACTH-secreting pituitary adenomas","volume":"121","author":"Fukuoka","year":"2011","journal-title":"J Clin Invest"},{"issue":"20","key":"2020071612075356500_B778","doi-asserted-by":"crossref","first-page":"8414","DOI":"10.1073\/pnas.1018091108","article-title":"Targeting zebrafish and murine pituitary corticotroph tumors with a cyclin-dependent kinase (CDK) inhibitor","volume":"108","author":"Liu","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"2020071612075356500_B779","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s11154-008-9082-4","article-title":"Somatostatin and dopamine receptors as targets for medical treatment of Cushing's Syndrome","volume":"10","author":"de Bruin","year":"2009","journal-title":"Rev Endocr Metab Disord"},{"issue":"12","key":"2020071612075356500_B780","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1055\/s-0031-1287769","article-title":"Somatostatin-dopamine chimeras: a novel approach to treatment of neuroendocrine tumors","volume":"43","author":"Culler","year":"2011","journal-title":"Horm Metab Res"},{"key":"2020071612075356500_B781","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1159\/000318499","article-title":"Pituitary carcinomas","volume":"38","author":"Colao","year":"2010","journal-title":"Front Horm Res"}],"container-title":["Endocrine Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/edrv\/article-pdf\/36\/4\/385\/11055780\/edrv0385.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/edrv\/article-pdf\/36\/4\/385\/11055780\/edrv0385.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T11:12:13Z","timestamp":1748430733000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/edrv\/article\/36\/4\/385\/2354703"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,1]]},"references-count":781,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,8,1]]}},"URL":"https:\/\/doi.org\/10.1210\/er.2013-1048","relation":{},"ISSN":["0163-769X","1945-7189"],"issn-type":[{"value":"0163-769X","type":"print"},{"value":"1945-7189","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,1]]}}}